CURRICULUM VITAE - ucalgary.ca · Web view1995-2000Alberta Heritage Foundation for Medical Research Scientist (competition renewal)

CURRICULUM VITAEQUENTIN J. PITTMAN

PERSONAL DATA

Birth Date: September 23, 1952 - Lethbridge, Alberta

Nationality: Canadian

Marital Status: Married (Jody Wood), 3 children

Address: Department of Physiology and Pharmacology and Hotchkiss Brain InstituteCumming School of MedicineUniversity of Calgary3330 Hospital Drive, N.W.Calgary, Alberta, CanadaT2N 4N1

Phone: (403) 220-7383 (office)(403) 220-4497 (lab)(403) 283-2700 (fax)(403) 978-7383 (cell)

E-mail: [email protected]

Web Site: http://www.ucalgary.ca/pittman/

EDUCATION

1969 High School, Lethbridge, Alberta

1972 Bachelor of Arts and Science - Major in BiologyUniversity of Lethbridge, Lethbridge, Alberta, Canada

1976 Ph.D. - Medical Physiology, University of Calgary,Calgary, Alberta, CanadaSupervisors: Dr. K. E. Cooper / W. L. Veale

POSITIONS

1976-1978 Post-doctoral Fellow - Division of Neurology, Montreal General Hospital and McGill University, Montreal, Quebec, CanadaSupervisor: Dr. L. P. Renaud

1978-1980 Post-doctoral Fellow - Arthur V. Davis Centre for Behavioral Neurobiology, Salk Institute, La Jolla, California, U.S.A.Supervisor: Dr. F. E. Bloom

1980-1984 Assistant Professor, Neuroscience Research Group and Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada

1984 Associate Professor, Neuroscience Research Group and Department of Pharmacology and Therapeutics, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada

1984-1988 Associate Professor, Neuroscience Research Group and Department of Medical Physiology, Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada

1988-present Professor, Neuroscience Research Group and Department of Physiology and Pharmacology (formerly Department of Medical Physiology), Faculty (now Cumming School) of Medicine, University of Calgary, Calgary, Alberta, Canada

1989-1990 Assistant Dean (Medical Science) Faculty of Medicine, University of Calgary, Calgary, Alberta, Canada

1992-1993 Visiting Scientist, INSERM U176, Bordeaux, France

2004- Full Member, Hotchkiss Brain Institute

2005-2012 Education Director, Hotchkiss Brain Institute

2005- Associate Member, Alberta Children’s Hospital Research Institute

2005- Associate Member, Snyder Institute for Chronic Diseases

2006-2011 University Professor, University of Calgary, Calgary, Alberta, Canada

2010- Adjunct Professor, Department of Pharmacology, University of Alberta, Edmonton, Alberta, Canada

2012- Member, Inflammation Research Network, University of Calgary

2015- Associate Member, Mathison Centre for Mental Health Research and Education, University of Calgary

AWARDS AND HONOURS

1969 Province of Alberta Matriculation Scholarship1971 Province of Alberta Undergraduate Scholarship1974 Davies Medical Research Scholarship, University of Calgary1974-1976 Medical Research Council Studentship, University of Calgary1976-1978 Medical Research Council Fellowship, McGill University1978 Fogarty International Fellowship of the National Institutes of Health (awarded

but not accepted)1978-1980 Medical Research Council Centennial Fellowship1980-1985 Medical Research Council Scholarship1985-1990 Alberta Heritage Foundation for Medical Research Scholarship

Last modified June 23, 2017

2

1985-1990 Medical Research Council Scientist1985 J.A.F. Stevenson Visiting Professorship Award of Canadian Physiological

Society1987 Alberta Heritage Foundation for Medical Research Visiting Scientist1987 International Brain Research Organization Visiting Lecturer1989 Canadian Association for Neuroscience Visiting Lecturer1990-1995 Alberta Heritage Foundation for Medical Research Scientist1992-1993 MRC - INSERM Visiting Scientist1994 Alumnus of the Year, University of Lethbridge1995-2000 Alberta Heritage Foundation for Medical Research Scientist (competition

renewal)1995-2000 Medical Research Council of Canada Senior Scientist1996 Grass Travelling Scientist1998 NeuroScience Canada Foundation Alberta Scholar2000-2005 Alberta Heritage Foundation for Medical Research Scientist (competition renewal)2003 University of Calgary, Outstanding Achievement in Supervision Award2004 MacIntosh Visiting Professorship Award of the Canadian Physiological Society2005-2010 Alberta Heritage Foundation for Medical Research Scientist (competition renewal)2006-2011 University Professor, University of Calgary2008 Canadian Physiological Society Sarrazin Award2008 Golden Apple Award, Outstanding Teaching Award2008 Distinguished Lectureship 2008, Integrative Physiology, University of Saskatchewan2008 Faculty of Medicine’s Smith Distinguished Achievement Award, University of

Calgary2010-2017 Alberta Heritage Foundation for Medical Research Scientist (competition renewal)2010- Fellow, Royal Society of Canada2013 Hellbender Honour Roll (teaching citation- Faculty of Medicine)2013 Mortyn Jones Memorial Lecturer, British Neuroendocrine Society2014 Honor Roll Award for Great Teaching (teaching citation- School of Medicine)2016 Joseph Erlanger Distinguished Lecturer, Am Physiol Soc2016- Fellow, Canadian Academy of Health Sciences

RESEARCH GRANTS

CURRENT

2017-2022 CIHR (Co-PI with M. Scantlebury, and R. Wilson)The role of TRPV1 receptors in the pathogenesis of febrile seizures

2002-2018 CIHR (Co-PI with K. A. Sharkey, PI)Endocannabinoids in the Regulation of Gastrointestinal Motility Disorders

2014-2019 CIHRCo-Morbid behaviours in Multiple Sclerosis: a mechanistic investigation in the EAE rodent model

2014-2019 NSERCSculpting brain circuits with early experience

2014-2019 CIHR (M Swain, PI, team grant)Brain Dysfunction in Chronic Inflammatory Disease


3

2014-2016 Brain Canada Multi Investigator Research Initiative (JS Bains, PI, team grant)Understanding Stress to Improve Mental Health

PAST

1983-2001 Heart and Stroke Foundation of Alberta and N.W.T. Pressor Action of Vasopressin (voluntary termination)

1987-1995 MRC MT-9842 (with B.A. MacVicar)Electrophysiology and Synaptic Physiology of Neuroendocrine Cells (voluntary termination)

1992-1995 NATO Collaborative Research Grant (with R. Landgraf) AVP and Oxytocin as Neurotransmitters in Autonomic Control

2001-2004 Heart and Stroke Foundation of Alberta and N.W.T. Hypothermia and Stroke (voluntary termination)

2007-2008 Alberta Children’s HospitalEffect of Maternal Fever on Seizure Susceptibility of the Neonatal Rat Brain (voluntary termination)

2003-2008 NSERC (with P. Whelan)Role of Vasopressin and Oxytocin in the Development and Control of Motor Activity (voluntary termination)

1998-2015 CIHR Plasticity of Neuroendocrine and Autonomic Synapses (voluntary termination)

2009-2014 NSERCLong-Term Changes in the Brain following Neonatal Seizures (voluntary termination)

1980-2016 CIHR Neonatal Programming by Inflammation(formerly: Neurophysiology and Pharmacology of Peptides in Brain) (voluntary termination)

2013-2016 AIHS (Co-PI with K.A. Sharkey and B. Kerr)A Mechanistic Investigation of Behavioral Co-Morbidity in Chronic Inflammatory Disorders

INFRASTRUCTURE GRANTS

1998-2003 Canadian Foundation for Innovation (G. Sutherland PI)Intra-operative MRI

2004-2009 Canadian Foundation for Innovation (G. Sutherland PI) Project neuroArm: MR compatible image guide robot for neurosurgery


4

TEACHING AND SUPERVISORY ACTIVITIES

1. Medical Student Traininga) Neuroscience Course - Receptors, Neurotransmitters, Antipyretics, Epilepsy, Neuroanatomy,

Thermoregulation and Fever, Pharmacology (lectures, small group seminars)b) Psychiatry Residents - Neuropharmacology (lectures)c) Introductory Course - Limbic System, Hypothalamus, Autonomic Nervous System (lectures),

General Physiology (small group seminars)

2. Graduate Student Teachinga) Neuroanatomyb) Pharmacologyc) Neuroscienced) Neuropharmacologye) Methods in Neurosciencesf) Advanced Neurophysiological Techniquesg) Cardiovascular Physiologyh) Gastrointestinal Physiology

3. Undergraduate Student Teachinga) Mammalian, comparative vertebrate and patho-physiologyb) Endocrinologyc) Basic neuroscienced) Neuropharmacologye) Undergraduate honours projectsf) Advanced techniques in neuroscienceg) Neuroimmunology

4. Graduate Student Supervision and Examination Committees

a) Advisory and Examination Committees (U of C):S. Werman, NEUROSCI J. Goldberg, NEUROSCIJ. English, MED SCI B. Sinclair, PSYCHK. Voshart, NEUROSCI B. Mustard, NEUROSCIG. Shillabeer, MED SCI A.M. Naylor, NEUROSCID. Gadotti, NEUROSCI M. O'Beirne, NEUROSCIE. Colebrook, NEUROSCI P. Federico, NEUROSCIG. Humphreys, NEUROSCI B. Wilcox, NEUROSCIM. Martinez-Padron, NEUROSCI B. Symons, NEUROSCIH. McLean, MED SCI D. Fraser, NEUROSCIW. Tetzlaff, NEUROSCI D. Ramatowski, NEUROSCIM. Rod, NEUROSCI K. Amundsen, NEUROSCIM. Papandriou, NEUROSCI C. Pearce,GASTROINTESTINALJ. Richmond, NEUROSCI M. Johns, NEUROSCI A. Fischer, NEUROSCI E. Parr, NEUROSCII. Ran, NEUROSCI C. Torgerson, CV/RESPH. Eliasson, MED SCI S. Chabot, NEUROSCID. Song, GASTROINTESTINAL B. Reuter, GASTROINTESTINAL M. Darby, NEUROSCI N. Lemon, NEUROSCIE. Flynn, NEUROSCI C. Armstrong, NEUROSCIS. Cubra-Farkas, CV/RESP M. Woodin, CV/RESP


5

K. Vasilakos, CV/RESP J. Hussein, CV/RESPS. Mulligan, NEUROSCI D. Munno, NEUROSCIL. Noonen, NEUROSCI P. van der Velde, GASTROINTESTINALA. Beadle, NEUROSCI B. McKay, NEUROSCIS. Jarvis, NEUROSCI C. Debert, MED SCIF. Fernandez, NEUROSCI N. Melvin, NEUROSCIG. Gordon, NEUROSCI M. Van Sickle, NEUROSCIS. Sangha, NEUROSCI K. Iremonger, NEUROSCIL. Lau, NEUROSCI S. Alam, NEUROSCIC. Doering, NEUROSCI A. Chambers, NEUROSCIT. Rice, NEUROSCI S. Peters, NEUROSCIG. Mak, NEUROSCI S. Gustafson,NEUROSCI, U of AT. Chomiak, NEUROSCI F. Zaamout, NEUROSCIF. Pang, BIOSCI R. Sterniczuk, PSYCHP. Ahluwalia, NEUROSCI C. Rider CV/RESPH. Altimimi, NEUROSCI J. McArthur, NEUROSCIS. Young, MEDSCI C. Young, PSYCH C. Duke, PSYCH B. Alexander, MED SCIC. D’Mello, IMMUNOL M. Dunbar, NEUROSCIE. Ferguson, NEUROSCI M. Hallam, KINESIOLOGYJ. Waamsteeker, NEUROSCI K. Nguyen, IMMUNOLT. Aavani, NEUROSCI J. Robinson, NEUROSCIN. Abraham, NEUROSCI M. Keough, NEUROSCID. Kar, NEUROSCI A. Nakashima, PSYCH S. Li, NEUROSCI V. Hoghooghi NEUROSCIL. Senst NEUROSCI C. Kinch BIOSCI

A. Beaudin, CV/RESP S. Nguyen, NEUROSCI J. Wamsteeker, NEUROSCI H. Vecchiarelli, NEUROSCI B. McAllister, PSYCH A Farran, NEUROSCIE. Mehina, NEUROSCI H. Leduc- Pessah, NEUROSCIM. Kaur, NEUROSCI K. Rawji, NEUROSCIK. Urban, NEUROSCI T. Klancic, KINESIOLOGYS Jensen, NEUROSCI M. Eaton BMBF Vincentini, GASTRO A. Spring, NEUROSCIJ Nettleton, KINESIOLOGY I. Goswami, NEUORSCIT. Johnson, BME V. Kiryanova, PSYCH

b) Supervisor:D. Burnard, Ph.D. P. Poulin, Ph.D.C. Riphagen, Ph.D. B. Bagdan, MD, M.Sc. J. Disturnal, MD,M.Sc. M. Earle, M.Sc.P. Williams, M.Sc., Ph.D. L. Boisse, MD, M.Sc.S. Pearson, M.Sc. J. Heida, Ph.D.M. Kozoriz, M.Sc. S. Ellis, Ph.D.M. Galic, MD, M.Sc., Ph.D. K. Crosby, M.Sc., Ph.D. (co-supervisor)A. Reid, MD, Ph.D. (co-supervisor) N. Nayani, M.Sc. T. Aavani, M.Sc. A. Hussin, M.Sc.(co-supervisor) A. Szubra, M.Sc.C. Marsters, Ph.D. (co-supervisor) M. Lewis, PhD (in Progress)V. Doenni, Ph.D. (in Progress) S. Candy, M.Sc. (co-supervisor)


6

c) Examining Committees (external):M. E. Cirino, Dept. of Neurology and Neurosurgery, McGill University Ph.D. Thesis, 1984V. Romita, Dept. of Physiology, McGill University, M.Sc. Thesis, 1986J. Jhamandas, Dept. of Neurology and Neurosurgery, McGill University, Ph.D. Thesis, 1987A. Obenaus, Dept. of Physiology, University of British Columbia, Ph.D. Thesis, 1989I. Neumann, Section of Biosciences, University of Leipzig, Dr. rer. nat, 1991D. Mouginot, Université Louis Pasteur, Strasbourg, Doctorat de l'Université, 1992P. Kremarik, Université Louis Pasteur, Strasbourg, Doctorat de l'Université, 1993T. Horn, Dept. of Cell Biology and Neurobiology, Dr. rer. nat. University of Leipzig, Germany 1994C. Jarvis, Dept. Neurology and Neurosurgery, McGill University, Ph.D. Thesis, 1994A. Mouihate, Dept. of Biochemistry and Cellular Biology, University of Bordeaux 2,

Doctorat de l'Université, 1995F. VanGoor, Dept. of Animal Physiology and Cell Biology, University of Alberta,

Ph.D.Thesis, 1996M. Cahoreau, Dept. of Neurosciences and Pharmacology, University of Bordeaux 2,

Doctorat de l'Université, 1997D. Richard, Dept. of Neurology and Neurosurgery, McGill University, Ph.D. Thesis, 1997R. W. Gilbert, Dept. of Pharmacology, Dalhousie University, Ph.D. Thesis, 1998A. Richmond, Dept. of Physiology, University of Texas, San Antonio, Ph.D. Thesis, 2000M. Ghamari-Langroudi, Dept. of Physiology, McGill University, Ph.D. Thesis, 2001C. Ferri, Dept. of Physiology, Queen’s University, Ph.D. Thesis, 2004M. Parsons, Dept of Medicine-Neuroscience, Memorial University, MSc Thesis, 2006S. Gustafsson, Dept of Pharmacology, University of Alberta, MSc Thesis, 2006S. Chabot, Dept of Neurology and Neurosurgery, McGIll University, Ph.D. Thesis, 2007D. Begg, Dept of Psychology, LaTrobe University, MSc Thesis, 2007D. Clark, Dept of Psychology, University of Alberta, Ph.D. Thesis, 2009K. Langdon, Faculty of Medicine, Memorial University, Ph.D. Thesis, 2010S. Zhu, Dept of Neuroscience, UBC, PhD Thesis, 2011K.A. Neufeld, Dept of Psychology, McMaster University, PhD Thesis, 2011 L. MacDonald, School of Psychological Sciences, LaTrobe University, PhD Thesis 2012C.Olechowski, Dept. of Neuroscience, University of Alberta, PhD Thesis, 2013M. Puskarjov, Dept. of Physiology and Neuroscience, University of Helsinki, PhD Thesis, 2013L. Sominsky, University of Newcastle, PhD Thesis, 2013A. Mimee, Queens University, Dept. of Physiology, PhD Thesis, 2014A. Taj, University of Karachi, Dept. of Microbiology, PhD Thesis, 2015I. Lecker, University of Toronto, Dept. of Physiology, PhD Thesis, 2015T. Dukhan, University of Witwatersrand, Dept. of Physiology, MSc Thesis, 2016V. Bansal, U Saskatchewan, Dept. of Physiology, Saskatoon, PhD Thesis 2016

d) Post-Doctoral Fellows:1. Duncan Lawrence - AHFMR Fellow, 1981-19842. William Colmers - AHFMR Fellow, 1984-19873. Tim Watson - AHFMR Clinical Research Fellow, 1984-19894. W.B. Mathieson - University Research Fellow, (co-supervised with WL Veale) 1987-19895. M. Wilkinson - MRC Fellow, 1990-19936. D. Porter - MRC Fellow, 1990-19947. F. Van Eerdenberg, HSFPO Fellow, 1991-19928. P. Poulin - Savoy Fellow, 1991-19939. I. Neumann - HSFPO Fellow, 1992-1994 and AHFMR Fellow, 1994-199510. P. Kremarik - U. of C. Fellow, 1993-1994 and HSFPO Fellow, 1994-1996


7

11. S. Kombian - MRC Centennial, Heart and Stroke Foundation Fellow, 1994-199812. B. Wilson - Heart and Stroke Foundation Fellow, 1995-199613. T. Saleh - AHFMR Fellow, 1995-199614. D. Mouginot - AHFMR Fellow, 1995-199815. X. Chen - MRC Fellow, 1995-199816. A. Mouihate - Heart and Stroke Foundation Fellow, 1996-1997 and MRC/PMAC Fellow,

1997-1999, University of Calgary Fellow 1999-200017. G. Kirouac - MRC Fellow, 1997-199918. M. Hirasawa - Japan Society for the Promotion of Science (JSPS), Japanese Junior

Scientist Fellow, 1997-1999; Heart & Stroke Foundation and CIHR Fellow 1999-200319. L. McCullough - Surgical Research Fellow (with M. Swain – co-supervisor) 1999-200020. M. Clerget - MRC /Hypertension Society Fellow, 1998-200021. Y-H. Zhang - Heart and Stroke Foundation Fellow, 1999-200122. H. Dong - NSERC/NRC/AstraZeneca Pharmaceuticals Partnership Fellow (with Dr. Dale

Corbett – co-supervisor), 1999-200023. C. Price - University of Calgary Fellow, 1999-200224. Y. Schwab - University of Calgary Fellow, 2001-2003 25. Z. Kiss - CIHR and AHFMR Clinical Investigator, 2001-200626. E.M. Harré - AHFMR Fellow, 2003-200727. N. Naderi - University of Calgary Fellow, 2003-200428. M. Duncan - AHFMR Fellow (with K. Sharkey – co-supervisor) 2004-200829. I. Spreadbury - University of Calgary Fellow (with K. Sharkey – co-supervisor) 2004-200630. N. Hyland - CAG Fellow (with K. Sharkey – co-supervisor) 2004-200731. S. Spencer - AHFMR/H&S/MRC Fellow, 2004-2007 32. M. Esser - Paediatric Neurology Research Fellow, 2004-200733. J.B. Kuzmiski - University of Calgary Fellow, 2004-2010 (with JS Bains)34. A. Zampronio - IBRO Fellow, 2005-200735. K. Riazi - University of Calgary Fellow 2006, AHFMR Fellow, 2007-2010 36. E. Field - AHFMR/CIHR Fellow, 2006-200837. N. McDonald - University of Calgary/Obesity Fellow, 2007-200838. R. Pearson - University of Calgary/Obesity Fellow, 2007-2008 (with K Sharkey)39. A. Reid - AHFMR, Killam, HBI Fellow, 2007-2010 (with GC Teskey)40. A. Kentner - AHFMR Fellow, 2007-201041. W. Inoue - AHFMR Fellow, 2009-2014 (with JS Bains)42. S. Rana - AHFMR Fellow, 2009-201443. F. Luo - AHFMR Fellow, 2009-2011 (with S Weiss)44. J. Boychuk - University of Calgary Fellow, 2010-2011 (with GC Teskey)45. T. Hoyda - HBI Fellow, 2010-2011 (with JS Bains)46. H. Khairy, University of Calgary Fellow, 2011-2012 (with K Sharkey)47. S. Acharjee – HBI Fellow, 2012-201348. M. Gray- HBI and AIHS Fellow, 2012- 2016 (with MN Hill)49. N. Kewir Yefon epse Dufe- HBI Fellow, 2014-2015; AIHS Fellow 2016- 50. D. Gomez, HBI and DDAC (Mexico) Fellow, 2015-51. V. Bansal, University of Calgary Fellow, 2016-52. J Read, University of Calgary Fellow 2017-53. C Matisz, University of Calgary Fellow 2017

e) Visiting Scientists:1. J. Ciriello, Dept. Physiology, University of Western Ontario, London, Canada2. A. Ferguson, Dept. Physiology, Queen's University, Kingston, Ontario, Canada3. S. Martin, Dept. Biology, Mount. St. Vincent University, Halifax, Ontario, Canada4. G. Siggins, Div. Preclinical Neuroscience, Scripps Institute, La Jolla, California, U.S.A.


8

5. J. Thornhill, Dept. Physiology, University of Saskatchewan, Saskatoon, Saskatoon, Canada

6. R. Landgraf, Institut für Psychiatrie - Max Planck Institut, Munich, Germany7. M. Monda, Universita Degli Studi di Napoli, Italy8. T. Horn, Section of Biosciences, Dept. of Cell Biology and Neurobiology, University of

Leipzig, Leipzig, Germany9. L. Branco, Dental School of Ribeirao Preto, University of Sao Paulo, Rebeirao Preto, Sao

Paulo, Brazil 10. E. Carnio, Nursing School of Ribeirao Preto, University of Sao Paulo, Rebeirao Preto, Sao

Paulo, Brazil11. C. Brown, Otago University, Dunedin, New Zealand12. L. Qulu, University of Kwa-Zulu Natal, Durban, South Africa13. M. Gutterville Leite, Federal University of Paraná, Brazil, South America

f) Faculty Mentorships:1. P. Federico, MD, Ph.D. 2. D.-M. McCafferty, Ph.D.3. R. Thompson, Ph.D. 4. J. Bains, Ph.D.5. P.-Y. Von der Weid, Ph.D. 6. Z. Kiss, MD, Ph.D.7. J. McDougall, Ph.D. 8. J. Braun, Ph.D.9. C. Gallagher, MD, M.Sc. 10. M. Esser, MD, Ph.D.11. D. Kurrasch, Ph.D. 12. P. Barber, MD13. M.Hill, Ph.D. 14. G. Giesbrecht, Ph.D.15. M. Scantlebury, MD 16. F. MacMaster, Ph.D.

EXECUTIVE ROLES IN SCIENTIFIC SOCIETIES

1985-1986 Nominating Committee, Canadian Physiological Society1987-1990 Membership Committee, Canadian Physiological Society1988-1991 Councillor, Canadian Physiological Society1993-1996 Nominating Committee, Canadian Physiological Society1995-1997 Membership Committee, Canadian Physiological Society1998 Task Force, International Society of Neuroendocrinology1999-2003 Councillor, International Federation of Neuroendocrinology2002-2005 Chair, Autonomic Nervous System section, IUPS (Intl Union of Physiological Sciences)

Commission on Neural Control2002-2004 Councillor, Canadian Association for Neuroscience2002-2004 President, Canadian Physiological Society2004-2006 Past President, Canadian Physiological Society2005-2013 Council Member, International Union of Physiological Societies2010-2016 Treasurer, International Brain Research Organization

REVIEWING ACTIVITIES

1. Journals

Many journals in neuroscience, neuroendocrinology, neuropharmacology, neurology, behavior, immunology and physiology.

2. Editorial Activities


9

1990- Editorial Board, "Future Health"1993-2006 Editorial Board and Reviewing Editor, Canadian Journal of Physiology and

Pharmacology1994- Editorial Board, American Journal of Physiology: Regulatory, Integrative and

Comparative Physiology1995-1997 Senior Editor (North America), Open Programs for Associative Learning2000-2007 Editorial Board and Reviewing Editor, Journal of Physiology (London)2000-2011 Receiving and Reviewing Editor, Journal of Neuroendocrinology 2003- Editorial Board, Drug Discovery Today: Disease Models2007-2013 Associate Editor, American Journal of Physiology: Regulatory, Integrative and

Comparative Physiology2010- Associate Editor, Frontiers in Neuroendocrine Science2011- Editorial Board, Brain, Behavior, and Immunity2013- Consulting Editor, Physiological Reports2013- Associate Editor, Brain, Behaviour, and Immunity2014- Section Editor and Editorial Board, Temperature2014- Associate Editor, eNeuro

3. Agencies

Alberta Heritage Foundation for Medical ResearchAstra Pharma Inc. RFP in ImmunologyAustralian Medical Research CouncilBiotechnology and Biological Sciences Research CouncilBritish Columbia Health Care Research FoundationBroad Medical Research FoundationCanada Research ChairsCanadian Foundation for Innovation Canadian Heart FoundationCanadian Foundation for AIDS ResearchCNPq (Brazil)Dravet FoundationEuropean Research CouncilFormation Chercheurs & Aide Recherche (FCAR)French National Research Agency (ANR)Heart and Stroke Foundation of CanadaInternational Human Frontier Science Program OrganizationIsrael Science FoundationManitoba Health Research FoundationMedical Research Council of CanadaNational Institutes of HealthNational Science FoundationNATO Scientific Affairs DivisionNatural Sciences and Engineering Research Council of CanadaNederlandse Organisatie voor Wetenschappelijk OnderzoekOntario Mental Health FoundationQatar National Research FundSaskatchewan Health Research BoardSwiss National Science FoundationThe Welcome Trust


10

4. Academic Appointment, Tenure and Promotion

Dept. of Anatomy, Queens University, Kingston, Ontario, CanadaDept. of Anatomy and Cell Biology, University of Alberta, Edmonton, Alberta, CanadaDept. of Anatomy and Cell Biology, University of South Carolina, Columbus, South Carolina, U.S.A.Dept. of Anatomy and Cell Biology, University of Western Ontario, London, Ontario, CanadaDept. of Medicine, University of Alberta, Edmonton, Alberta, CanadaDept. of Medicine, University of California, San Diego, San Diego, California, U.S.A.Dept. of Neuroscience, University of California, Riverside, California, U.S.ADept. of Pharmacology, Dalhousie University, Halifax, NS, CanadaDept. of Pharmacology, University of Arizona, Tucson, Arizona, U.S.A.Dept. of Pharmacology, University of Washington, Seattle, Washington, U.S.A.Dept. Physiology, McGill University, Montreal, Quebec, CanadaDept. Physiology, Queen's University, Kingston, Ontario, CanadaDept. of Physiology, The Oregon Health Science University, Portland, Oregon, U.S.A.Dept. of Physiology, University of British Columbia, Vancouver, British Columbia, CanadaDept. of Physiology, University of Manitoba, Winnipeg, Manitoba, CanadaDept. of Physiology, University of Western Ontario, London, Ontario, CanadaDept. of Physiology/Biophysics, University of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.ADept. of Psychology, University of Colorado, Boulder, Colorado, U.S.A.Division of Neurology, University of Alberta, Edmonton, Alberta, CanadaLoeb Medical Research Institute, Ottawa Civic Hospital, Ottawa, Ontario, CanadaSchool of Kinesiology, Simon Fraser University, Burnaby, British Columbia, CanadaDept. of Pharmacology, University of Texas Health Science Center, San Antonio, TexasDept. of Psychology, La Trobe University, Melbourne, AustraliaDept. Anatomy & Cell Biology, Dalhousie University, Halifax, Nova Scotia, CanadaDept. of Psychiatry, University of British Columbia, Vancouver, British Columbia, CanadaDept. of Medicine, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, CanadaDept. of Anatomy & Cell Biology and Psychiatry, McGill University, Montreal, Quebec, CanadaDept. of Anatomy & Neurobiology, Dalhousie University, Halifax, Nova Scotia, CanadaDept. of Kinesiology, University of Calgary, Calgary, Alberta, CanadaDept. of Neuropharmacology, The Scripps Research Institute, La Jolla, California, U.S.A.Dept. of Physiology, University of Alberta, Edmonton, Alberta, CanadaDept. of Anesthesia, University of Toronto, Toronto, Ontario, CanadaCollege of Medicine and Veterinary Medicine, University of Edinburgh, Edinburgh, United KingdomDept. of Physiology, University of Toronto, Toronto, Ontario, CanadaCollege of Medicine and Veterinary Medicine, Royal (Dick) School of Veterinary Medicine, University of Edinburgh, Edinburgh, United Kingdom Dept. of Physiology and Pharmacology, University of Western Ontario, London, Ontario, CanadaDept. of Medicine, Memorial University of Newfoundland, St. John’s, Newfoundland, CanadaDept. of Psychiatry and Neuroscience, Laval University, Quebec, Quebec, CanadaDept. of Psychiatry, McGill University, Montreal, Quebec, CanadaCollege of Medicine and Veterinary Medicine, Royal (Dick) School of Veterinary Medicine, University of Edinburgh, Edinburgh, United KingdomDept. of Neurobiology, University of California Los Angeles, Los Angeles, California, USADept. of Pediatrics, University of California, Irvine, Irvine, California, USADept. of Physiology, University of Saskatchewan, CanadaDept. of Psychology, University of British Colombia, Vancouver, CanadaDept. of Pharmacology, United Arab Emirates, Al Ain, United Arab EmiratesDivision of Anatomy, University of Alberta, Edmonton CanadaSchool of Biomedical Sciences, University of Newcastle, Newcastle Australia


11

Dept. of Neuroscience, Carleton University, Ottawa, Ontario, CanadaDept. of Human Anatomy and Cell Science, University of Manitoba, Winnipeg, ManitobaDept. of Physiology, University of Otago, Dunedin, New ZealandSchool of Health Sciences, RMIT University, Melbourne, AustraliaDept. of Anesthesiology, Pharmacology & Therapeutics, University of British Columbia, British ColumbiaDept. of Psychology and Neuroscience, Duke University, Durham, NC, USADept. of Pediatrics, Harvard Medical School, Boston, MA USADept of Pharmacology and Neuroscience, University of North Texas Health Science Center, Fort Worth , TXUniversity of Pretoria, South Africa

5. Review Committees

1980 Member, Alberta Heritage Medical Research Foundation, Grants Review Committee Site Visit, Edmonton, Alberta, Canada

1982-1986 MRC Grants Review Committee for Neuroregulatory Mechanisms1985-1987 AHFMR Major Equipment Grant Committee1986 Ad hoc member, Neurobiology Study Section, National Institutes of Health,

Bethesda, Maryland, U.S.A. 1986-1988 Scientific Review Committee, Canadian Heart Foundation1987 Ad hoc member, MRC Grant Review Committee for Neuroscience1989 Ad hoc member, Neurobiology Study Section, National Institutes of Health,

Bethesda, Maryland, U.S.A.1989 Member MRC Program Grant Review Committee Site Visit, Quebec, Canada1990-1992 Fellowship Review Committee, International Human Frontier Science Program

Organization, Strasbourg, France (Chairman, 1990, 1991)1990 Ad hoc member, Behavioral Neuroscience Study Section, NIAADA, U.S.A.1990 Member, MRC Development Grant Review Committee Site Visit, Ottawa, Ontario, 1992 Chairman, Medical Research Council Program Grant Review Committee Site Visit,

McGill University, Montreal, Quebec, Canada1992 Member, Medical Research Council Program Grant Review Committee, Site Visit,

Université de Montreal, Montreal, Quebec, Canada1993-1996 Fellowship Review Committee, Heart and Stroke Foundation of Canada1994 Chairman, MRC Program Grant Review Site Visit, CNRS - Santé, Montreal, Quebec, 1996-1999 Chairman, Fellowship Review Committee, Heart & Stroke Foundation of Canada1996 Chairman, MRC Program Grant Review Site Visit, University of Toronto, Toronto, 1996 Ad hoc Grant Review Committee, National Institutes of Health, Bethesda, Maryland, U.S.A.1997-1999 Member, MRC Pharmacology and Toxicology Grant Committee1998-1999 Endowed Research Chair Review Committee, Heart & Stroke Foundation of Ontario1999 External Reviewer, Department of Physiology, University of Toronto, Toronto, Ontario2000 Member, Heart and Stroke Foundation of Canada/Ontario Program Grant Review

Committee Site Visit - University of Ottawa, Ottawa, Ontario, Canada2000 Member, Heart and Stroke Foundation of Canada/Ontario Program Grant Review

Committee Site Visit - University of Toronto, Toronto, Ontario, Canada2000 Member, Heart and Stroke Foundation of Canada/Ontario Program Grant Review

Committee Site Visit - Queen’s University, Kingston, Ontario, Canada2000 Member, Review Committee, CFI Innovation applications, FRSQ, Quebec2000 Ad hoc member, Integrative, Functional and Cognitive Neuroscience Committee,

National Institutes of Health, Bethesda, Maryland, U.S.A.


12

2000- Member, College of Reviewers, Canada Research Chairs2001 Member, Heart and Stroke Foundation of Canada/Ontario Program Grant Review

Committee Site Visit - University of Western Ontario, London, Ontario, Canada2001-2004 Member, Canadian Institutes of Health Research, (CIHR) Group Grant Review

Committee2001 Member, Heart and Stroke Foundation of Canada/BC & Yukon Grant Review

Committee Site Visit - UBC and Simon Fraser University, Vancouver, British Columbia2001 Member, Heart and Stroke Foundation of Ontario, Stroke Center of Excellence Review

Committee2001 Member, Robarts Research Institute, Program Grant Review Committee Site Visit,

London, Ontario, Canada2001 Member, Heart and Stroke Foundation of Canada/BC & Yukon Program Grant Review

Committee Site Visit - University of BC, Vancouver, British Columbia, Canada2002 Member, Heart and Stroke Foundation of Ontario, Program Grant Review Committee

Site Visit, University of Western Ontario, London, Ontario, Canada2002 Member, FRSQ Neuroscience and Mental Health Network Site Visit, Montreal, Quebec2002 Member, CNRS Site Visit to review CNRS UMR 5101 (Biologie des Neurones

Endocrines) Montpellier, France2003 External Reviewer & Site Visitor Centre de recherche en sciences neurologiques,

Université de Montréal, Montreal, Quebec, Canada2003-2006 Ad hoc member-Neuroendocrinology, Neuroimmunology and Behavior study section,

National Institutes of Health, U.S.A.2005- CRC Review Committee2005 Member, FRSQ Neuroscience and Mental Health Network Site Visit, Montreal, Quebec2005 Member, Heart and Stroke Foundation of Canada/Ontario Program Grant Review

Committee Site Visit - Queen’s University, Kingston, Ontario and University of Toronto.2006 Member, Heart and Stroke Foundation of Canada/Ontario Program Grant Review

Committee Site Visit - University of Ottawa and University of Western Ontario2006-2010 Full Member, Neuroendocrinology, Neuroimmunology and Behavior study section,

National Institutes of Health, U.S.A.2011 Ad hoc Review committee member, CIHR Neuroscience A committee2011 Member, German Research Foundation, Clinical Research Unit, Review Committee,

Dresden, Germany2011 Full member, NIH Special Emphasis study section, National Institutes of Health, ,

U.S.A.2012 Ad hoc Review committee member, CIHR Behavioral Sciences A committee2012 Full member, NIH Special Emphasis study section, National Institutes of Health,

Center for Scientific Review, Bethesda, Maryland, U.S.A.2012- Campus Alberta Neuroscience Review Committee # of reviews 10/year2013-2015 Review Committee Member, CIHR Neuroscience A Committee 2014-2017 CIHR Vanier Canada Graduate Scholarships Selection Committee2014-2015 Member, Foundation Scheme Review Committee, CIHR2014-2015 Member, Dravet.ca Review Committee2016- NSERC RTI Equipment review committee2016 Ad hoc Member, NNRS study Section, NIH2016 Ad hoc member, DBD study Section, NIH2017 Ad hoc member, Special Emphasis Panel, BRLE and MESH study sections, NIH

COMMITTEE ACTIVITIES (The University of Calgary)


13

1975-1976 Executive Faculty Council, Faculty of Medicine, University of Calgary1975-1976 Student Promotions Committee, Faculty of Medicine, University of Calgary1980-1983 Medical Sciences Program Sub-committee of Committee on Research, University of

Calgary1981-1982 Internal Review Committee - Arctic Institute of North America1982-1984 Committee on Research, Faculty of Medicine, University of Calgary1982-1984 Research Policy and Grants Committee, University of Calgary1982-1984 Committee for Visiting Lecturers, University of Calgary1983-1985 Chairman, Neuroscience Research Group1985-1986 Ad Hoc Subcommittee of Committee on Research for Faculty Workshop1985-1986 Nominating Committee, Faculty of Medicine1980- Numerous Search Committees, Neuroscience Research Group1986-1988 Student Appeals Committee, Faculty of Medicine1987-1989 Faculty of Graduate Studies Scholarship Committee1988-1990 Executive Faculty Council, Faculty of Medicine1989-1990 Faculty of Graduate Studies Council1990 Internal Review, Department of Medical Science1991-1992 Search Committee, CIBA-Geigy, Chair in Schizophrenia1991-1992 Chairman, Committee on Research, Faculty of Medicine1991-1992 Research Advisory and Policy Committee1991-1992 Search Committee, Director of Animal Resources Centre1991-1992 Roy Allen Eyesight Research Endowment Advisory Committee1995-2005 Executive Committee, Neuroscience Research Group1995-1997 Faculty of Science Council1995-1998 Nominating Committee, Faculty of Medicine1997-1999 Academic Appointment Review Committee1997-1999 Travel Committee, Faculty of Medicine1997-1999 Travel Advisory Committee - University of Calgary1997-2007 Postdoctoral Advisory Committee, Faculty of Medicine1997-1998 Ad hoc Advisory Committee on Basic Science Department Structure1998-2000 Dean’s Advisory Committee, Faculty of Medicine1998-2006 Member. Postdoctoral Education Committee1998 MRC Council Meeting, Program Advisory Committee1998 Ad hoc Faculty Advisory Committee to International Board of Review of AHFMR1998 Search Committee, Chair of Biochemistry and Molecular Biology2000 Search Committee, NSERC Woman's Chair, Department of Psychology2001 Articular Physiology Search Committee, Department of Physiology2001 Academic Search Committee, Department of Physiology2002-2005 Executive Committee, NEUROSCI2002-2012 Graduate Education Committee, Department of Neuroscience2002-2003 Fundraising Committee, NEUROSCI2003-2004 Search Committee for Dean, Faculty of Nursing2004-2012 Chair, Education Committee, Hotchkiss Brain Institute, University of Calgary2004 Academic Appointment Selection Committee, Behavioural Neuroscience, Department

of Psychology, University of Calgary2004-2012 Executive Committee, Hotchkiss Brain Institute, University of Calgary2004-2007 Research Committee, Hotchkiss Brain Institute, University of Calgary2004-2005 Annual Academic Review Committee (AARC), University of Calgary2005- Internal review committee, CRC applications (chair; 2006-)2007 Internal Review committee, AHFMR Team grant applications (chair)2006-2007 Search Committee for Vice President Research, University of Calgary


14

2008 Annual Academic Review Committee (AARC), University of Calgary2008-2012 BSc Neuroscience Education Committee, University of Calgary2009- Search, Selection and Advisory Committee for the Haslam Chair in Pediatric

Neurology, University of Calgary2009- Advisory Committee for the Novartis Chair in Schizophrenia Research, University of

Calgary2009-2010 Selection Committee for Scientist in Cellular and Molecular Basis of Mental Health,

University of Calgary2009-2010 Campus Alberta Neuroscience Planning and Task Force Committee2010 Masters Education Program Director Selection Committee, University of Calgary2010 Academic Appointment Review Committee (AARC), University of Calgary2010 General Promotions Committee, University of Calgary2010 Pain Executive Group, Department of Physiology and Pharmacology, University of Calgary2010-2012 Neural Systems Leadership Committee, Hotchkiss Brain Institute, University of Calgary2010-2011 Chair, Faculty of Medicine Review Committee on Institutes2010 CIHR Training Program in Genetics, Child Development and Health, Basic Science

Graduate Review Committee, University of Calgary2010 Academic Appointment Appeal Committee, University of Calgary2010-2015 Advisory Committee- Hopewell Professorship2011- Faculty of Medicine Awards Committee2011 Search and Selection Committee for the Academic Pediatric Physician within the

Division of Pediatric Neurology2011-2014 Rebecca Hotchkiss International Scholar Exchange Program Committee, University of

Calgary2011 Committee of Investigation (ethics), University of Calgary2011 Search and Selection Committee for the Academic Pediatric trauma specialist within

the Division of Pediatric Neurology2012- Hotchkiss Brain Institute Trainee award review committee (Chair)2012 Committee of Investigation (ethics), University of Calgary2012- Internal Banting Fellowship Review Committee2012- SUPPORT: Training and professional development subcommittee2012- Cumming School of Medicine Alumnus Committee2013-2015 Eyes High Postdoctoral Evaluation Committee2013- Infrastructure Director, HBI2013- Center for Advanced Technologies (CAT) Finance and Review Committee2013- Strategic Research and Innovation Committee, HBI2014- Executive Committee, Dept of Physiology & Pharmacology2014-2015 Eyes High Graduate Student Evaluation Committee2014-2015 I3T Fellowship Review Committee2014- Medical Student Appeals Committee (chair, 2016-)2014-2015 Microbiome Committee2014- UCare Committee, University of Calgary2015- General Faculties Council2015-2016 HBI Team Grant Review Committee (chair)2016- Graduate Academic Program Subcommittee of GFC

COMMITTEE ACTIVITIES (Other Academic- National and International)

ORGANIZING AND PROGRAM COMMITTEES


15

1981 Local Organizing Committee, 32nd Annual Meeting, American Society forPharmacology and Experimental Therapeutics, Calgary, Alberta, Canada

1981 Organizer (with K. Lederis) symposium on "Neural Peptides in Homeostatic Function", ASPET Meeting, Calgary, Alberta, Canada

1985-1986 Programme Committee, Heritage Days1985-1986 Organizer (with D. Brown) symposium on "Mechanism of peptide action on nerve

cells", XXX International Congress of Physiological Sciences, Vancouver, BC1988-1989 National Advisory Committee, International Narcotic Research Conference1989-1991 International Organizing Committee, Fourth International Reinhardsbrunn Symposium1995-1997 Organizing Committee, The 1997 World Congress of Neurohypophysial Hormones

Canada1997-1998 Program Committee, International Congress of Neuroendocrinology2000-2001 Member, International Advisory Board, World Congress on Neurohypophysial

Hormones, Bordeaux, France 2000-2002 Member, Program Committee, International congress of Neuroendocrinology,

Organizing Committee2001-2003 Member, Program and Organizing Committee, International Society for Autonomic

Neuroscience Congress2003 Member, Program Committee, World Congress of Neurohypophysial Hormones, Kyoto, Japan2003-2004 Member, Program Committee, Société de Neuroendocrinologie joint Quebec-France

meeting, Montpellier, France 20042005-2007 Member, Program Committee, World Congress of Neurohypophysial Hormones,

Regensburg Germany2006-2009 Member, Program Committee, International Congress of Physiological Sciences,

Kyoto 20092008-2009 Member, Program Committee, World Congress on Neurohypophysial Hormones,

Kitakyushu, Japan2010 Member, Organizing Committee, Immunity and Inflammation in Epilepsy, Milan 20102010-2014 Chair, Program Committee, International Congress of Neuroendocrinology, Sydney,

Australia 20142011-2013 Member, Program Committee, International Congress of Physiological Sciences,

Birmingham, UK 20132014- Member, Local Organizing Committee, International Congress of Neuroendocrinology,

Toronto, Canada 2018

OTHER COMMITTTEES

1988 MRC Conference on Medical Research in Canada - Direction for the Future1991-1993 Program Advisory Committee, Alberta Heritage Foundation for Medical Research1996 Ad hoc Nominating Committee, Neuroscience A and B Grants Committee of MRC1996- Armin Ermisch Memorial Award Committee, Munich, Germany1997 Member, MRC Regional Retreat, Vancouver, British Columbia, Canada1998 Member, WHO informal meeting on the Autonomic Nervous System, Bethesda,

Maryland, U.S.A.2000 Member, Coordinating Group, Canadian Network for Neuroimmune Biology2004 Member, CIHR Research Consultation on Early Life Events and First Episodes of

Brain Disorders2004 Member, CIHR Research Consultation on Epilepsy2008-2009 Member, AHFMR Trainee Program Review Advisory Committee


16

2009-2011 Member, Canadian Association for Neuroscience Nominating Committee2010 Member, AIHS Professional Development Advisory Committee2010- endMS National Education and Training Committee2015-2020 Member, Finance Committee, Society for Neuroscience2017 SFN Prerpint Working Group Committee

CONSULTING ACTIVITIES

2003- 2007 CV Therapeutics, Palo Alto, California2004- SubCue Inc, Calgary, Alberta2012 Lundbeck, Denmark

COMMITTEE ACTIVITIES (Community)

1981-1983 Citizens Advisory Committee to City Council1984-1987 Member, Board of Directors, Calgary Distress Centre/Drug Centre1985-1988 Member, Board of Directors, Theatre Calgary1986 Judge, Canada-Wide Science Fair1996-1997 Member, Alberta Science & Research Authority, Research & Development Workshop2000 Keynote Speaker, Career Day, John G. Diefenbaker High School, March 1, 20002002-2003 Member, City Council Advisory Committee, Pathway and Walkways

KNOWLEDGE TRANSFER2017 Brain Health MLA Breakfast, Edmonton, Alberta

PUBLISHED REFEREED RESEARCH PAPERS (Total citations: >10,000; h-index: 54; Web of Science)

1. BOYCHUCK, J.A., FARRELL, J.S., PALMER, L.A., SINGLETON, A.C., PITTMAN, Q.J., TESKEY, G.C., HCN channels segregate stimulation-evoked movement responses in neocortex and allow for coordinated forelimb movements in rodents. J Physiol. 2017 Jan 1;595(1): 247-263.DOI: 10.1113/JP273068.

2. DOENNI, V.M., SONG, C.M., HILL, M.N., Pittman, Q.J., (2016) Early-life inflammation with LPS delays fear extinction in adult rodents. Brain Behav Immun. 2016 Nov 22 pii: S0889-1591(16) 30524-4.DOI: 10.1016/jbbi.2016.11.022. [Epub ahead of print]

3. MARSTERS, C.M., ROSIN, J.M., THORNTON, H.F., ASLANPOUR, S., KLENIN, N., WILKINSON, G., SCHUURMANS, C., PITTMAN, Q.J., KURRASCH, D.M., (2016) Oligodendrocyte development in the embryonic tuberal hypothalamus and the influence of Ascl1. Neural Dev. 2016 Nov 18;11(1):20.

4. DOENNI, V.M., GRAY, J.M., SONG, C.M., HILL, M.N., Pittman, Q.J., (2016) Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling. Brain Behav Immun. 2016 Nov; 58:237-247. doi: 10.1016/j.bbi.2016.07.152.

5. GRAY, J.M., WILSON, C.D., LEE, T.T., PITTMAN, Q.J., DEUSSING, J.M., HILLARD, C.J., MCEWEN, B.S., SCHULKIN, J., KARATSOREOS, I.N., PATEL, S., HILL, M.N., (2016) Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate


17

endocannabinoid function. Psychoneuroendocrinology. 2016 Jan11; 66:151-158. DOI: 10.1016/j.psyneuen.2016.01.004.

6. MARSTERS, C.M., KURRASCH, D.M., PITTMAN, Q.J., (2015) Influence of microglia during tuberal hypothalamic development. Int J Dev Neurosci. 2015 Dec; 47(Pt A):108. DOI: 10.1016/j.ijdevneu.2015.04.294.

7. CROSBY, K.M., BAIMOUKHAMETOVA, D.V., BAINS, J.S., PITTMAN, Q.J., (2015) Postsynaptic depolarization enhances GABA drive to dorsomedial hypothalamic neurons through somatodendritic cholecystokinin release. J Neurosci. 35:13160-70. DOI: 10.1523/JNEUROSCI.3123-14.

8. HUSSIN, A.T., BOYCHUK, J.A., BROWN, A.R., PITTMAN, Q.J., TESKEY, G.C., (2015) Intracortical Microstimulation (ICMS) Activates Motor Cortex Layer 5 Pyramidal Neurons Mainly Transsynaptically. Brain Stimul 8(4):742-50. DOI: 10.1016/j.brs.2015.03.003.

9. AAVANI, T., RANA, S.A., HAWKES, R., PITTMAN, Q.J., (2015) Maternal Immune Activation Produces Cerebellar Hyperplasia and Alterations in Motor and Social Behaviors in Male and Female Mice. Cerebellum 14: 491-505 Oct DOI 10.1007/s12311-015-0669-5

10. RIAZI, K., GALIC, M.A., KENTNER, A.C., REID A.Y., SHARKEY, K.A., PITTMAN, Q.J. (2015) Microglia-dependent alteration of glutamatergic transmission and plasticity in the hippocampus during peripheral inflammation. J.Neurosci 35 (12):4942-52.

11. D’MELLO, C., RIAZI, K., LE, T., STEVENS, K.M., WANG, A., MCKAY, D.M., PITTMAN, Q.J., SWAIN, M.G. (2013) P-selectin-mediated monocyte-cerebral endothelium adhesive interactions link peripheral organ inflammation to sickness behaviors. J Neurosci ;33(37):14878-88

12. MORIYAMA, C., GALIC, M.A., MYCHASIUK, R., PITTMAN, Q.J., PERROT, T.S., CURRIE, R.W., ESSER, M.J. (2013) Prenatal transport stress, postnatal maternal behavior, and offspring sex differentially affect seizure susceptibility in young rats. Epilepsy Behav. 2013 Aug 3;29(1): 19-27

13. ACHARJEE, S., NAYANI, N., TSUTSUI, M., HILL, M.N., OUSMAN, S.S., PITTMAN, Q.J. (2013) Altered cognitive-emotional behavior in early experimental autoimmune encephalitis- Cytokine and hormonal correlates. Brain Behav Immun. Oct;33:164-72

14. DUNCAN, M., GALIC, M.A., WANG, A., CHAMBERS, A.P., MCCAFFERTY, D.M., MCKAY, D.M., SHARKEY, K.A., PITTMAN, Q.J. (2013) Cannabinoid (CB)1 receptors are critical for the innate immune response to TLR4 stimulation. Am J Physiol Regul Integr Comp Physiol 305(3):R224-31

15. INOUE, W., BAIMOUKHAMETOVA, D.V., FÜZESI, T., CUSULIN, J.I., KOBLINGER, K., WHELAN, P.J., PITTMAN, Q.J., BAINS, J.S. (2013) Noradrenaline is a stress-associated metaplastic signal at GABA synapses. Nat Neurosci. 5:605-12

16. SCULLION, K., BOYCHUK, J.A., YAMAKAWA, G.R., RODYCH, J.T., NAKANISHI, S.T., SETO, A., SMITH, V.M., MCCARTHY, R.W., WHELAN, P.J., ANTLE, M.C., PITTMAN, Q.J., TESKEY, G.C. (2013) Serotonin 1A receptors alter expression of movement representations. J Neurosci. 33:4988-99


18

http://www.ncbi.nlm.nih.gov/pubmed/24027287





17. REID, A.Y., RIAZI, K., TESKEY, G.C., PITTMAN, Q.J. (2013) Increased excitability and molecular changes in adult rats after a febrile seizure. Epilepsia: 54(4):e45-8

18. HU, H., HO, W., MACKIE, K., PITTMAN, Q.J., SHARKEY, K.A. (2012) Brain CB(1) receptor expression following lipopolysaccharide-induced inflammation. Neuroscience: 227:211-222

19. HONS, I.M., STORR, M.A., MACKIE, K., LUTZ, B., PITTMAN Q.J., MAWE, G.M., SHARKEY, K.A. (2012), Plasticity of mouse enteric synapses mediated through endocannabinoid and purinergic signaling. Neurogastroenterol Motil 24: e113-e124

20. HENDERSON, A.K., PITTMAN, Q.J., TESKEY, G.C. (2012) High frequency stimulation alters motor maps, impairs skilled reaching performance and is accompanied by an upregulation of specific GABA , glutamate and NMDA receptor subunits. Neuroscience 215: 98-113

21. TOBIN, V., SCHWAB, Y., LELOS, N., ONAKA, T., PITTMAN, Q.J., LUDWIG, M. (2012) Expression of Exocytosis Proteins in Rat Supraoptic Nucleus Neurones. J Neuroendocrinol. 24 (4):629-641

22. REID, A.Y., PITTMAN, Q.J., TESKEY, G.C. (2012) A prolonged experimental febrile seizure results in motor map reorganization in adulthood. Neurobiol Dis. 45(2):692-700.

23. HENDERSON, A.K., GALIC, M.A., FOUAD, K., DYCK, R.H., PITTMAN, Q.J., TESKEY, G.C. (2011) Larger cortical motor maps after seizures. Eur J Neurosci. 34:615-621.

24. CROSBY, K.M., INOUE, W.I., PITTMAN, Q.J., BAINS, J.S. (2011) Endocannabinoids gate state-dependent plasticity of synaptic inhibition in feeding circuits. Neuron. 71:529-541.

25. ZAMPRONIO, A.R., KUZMISKI, J.B., FLORENCE, C.M., MULLIGAN, S.J., PITTMAN, Q.J. (2010) Opposing actions of endothelin-1 on glutamatergic transmission onto vasopressin and oxytocin neurons in the supraoptic nucleus. J Neurosci. 30(50):16855-16863

26. HYLAND, N.P., RYBICKA, J.M., HO, W., PITTMAN, Q.J., MACNAUGHTON, W.K., SHARKEY, K.A. (2009) Adaptation of intestinal secretomotor function and nutrient absorption in response to diet-induced obesity. Neurogastroenterol Motil. 22(6):602-e171

27. MOUIHATE, A., GALIC, M.A., ELLIS, S.L., SPENCER, S.J., TSUTSUI, S. PITTMAN, Q.J. (2010) Early life activation of toll-like receptor 4 reprograms neural anti-inflammatory pathways. J Neurosci. 30(23):7975-7983

28. KENTNER, A.C., MCLEOD, S.A., FIELD, E.F., PITTMAN, Q.J., (2010) Sex-dependent effects of neonatal inflammation on adult inflammatory markers and behavior. Endocrinology. 151(6):2689-2699

29. SPENCER, S.J., FIELD E., PITTMAN, Q.J. (2010) Neonatal programming by neuroimmune challenge: Effects on responses and tolerance to septic doses of lipopolysaccharide in adult male and female rats. J Neuroendocrinol. 22(4):272-281


19

30. HYLAND, N.P., CHAMBERS, A.P., KEENAN, C.M., PITTMAN, Q.J., SHARKEY, K.A. (2009) Differential adipokine response in genetically-predisposed lean and obese rats during inflammation; a role in modulating experimental colitis? Am J Physiol Gastrointest Liver Physiol. 297(5):G869-G877

31. GALIC, M.A., RIAZI, K., HENDERSON, A.K., TSUTSUI, S., PITTMAN, Q.J. (2009) Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats. Neurobiol Dis. 36:343-351

32. KUZMISKI, J.B., PITTMAN, Q.J., BAINS, J.S. (2009) Metaplasticity of hypothalamic synapses following in vivo challenge. Neuron. 62(6):839-849

33. ELLESTAD, K.K., TSUTSUI, S., NOORBAKHSH, F., WARREN, K.G., YONG, V.W., PITTMAN, Q.J., POWER, C. (2009) Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells. J Immunol. 183(1):298-309

34. NATAH, S.S., SRINIVASAN, S., PITTMAN, Q.J., ZHAO, Z., DUNN, J.F. (2009) Effects of acute hypoxia and hyperthermia on the permeability of the blood brain barrier in adult rats. J Appl Physiol. 107(4):1348-1356

35. RIAZI, K., GALIC, M.A., KUZMISKI, J.B., HO, W., SHARKEY, K.A., PITTMAN, Q.J. (2008) Microglial activation and TNFα production mediate altered CNS excitability after peripheral inflammation. Proc Natl Acad Sci 105(44):17151-17156

36. GALIC, M.A., RIAZI, K., HEIDA, J.G., MOUIHATE, A., FOURNIER, N.M., SPENCER, S.J., KALYNCHUK, L.E., TESKEY, G.C., PITTMAN, Q.J. (2008) Postnatal inflammation increases seizure susceptibility in adult rats. J Neurosci. 28(27):6904-6913

37. DUNCAN, M., MOUIHATE, A., MACKIE, K., KEENAN, C.M., BUCKLEY, N.E., DAVISON, J.S., PATEL, K.D., PITTMAN, Q.J., SHARKEY, K.A. (2008) Cannabinoid CB2 receptors in the enteric nervous system modulate gastrointestinal contractility in lipopolysaccharide-treated rats. Am J Physiol Gastrointest Liver Physiol. 295(1):G78-87

38. SPENCER, S.J., GALIC, M.A., TSUTSUI, M., PITTMAN, Q.J., MOUIHATE, A. (2008) Effects of global cerebral ischemia in the pregnant rat. Stroke. 39(3):975-982

39. HARRE, E.M., GALIC, M.A., MOUIHATE, A., NOORBAKHSH, F., PITTMAN, Q.J. (2008) Neonatal inflammation produces selective behavioural deficits and alters N-methyl-D-aspartate receptor subunit mRNA in the adult rat brain. Eur J Neurosci. 27(3):644-653

40. CHAMBERS, A.P., VEMURI, V.K., PENG, Y., WOOD, J.T., OLSZEWSKA, T., PITTMAN, Q.J., MAKRIYANNIS, A., SHARKEY, K.A. (2007) A neutral CB1 receptor antagonist reduces weight gain in rat. Am J Physiol Regul Integr Comp Physiol. 293(6):R2185-2193

41. SPENCER, S.J., MOUIHATE, A., GALIC, M.A., ELLIS, S.L., PITTMAN, Q.J. (2007) Neonatal immune challenge does not affect body weight regulation in rats. Am J Physiol Regul Integr Comp Physiol. 293(2):R581-589


20

42. HYLAND, N.P., PITTMAN, Q.J., SHARKEY, K.A. (2007) Peptide YY containing enteroendocrine cells and peripheral tissue sensitivity to PYY and PYY(3-36) are maintained in diet-induced obese and diet-resistant rats. Peptides. 28(6):1185-1190

43. SHARKEY, K.A., CRISTINO, L., OLAND, L.D., VAN SICKLE, M.D., STAROWICZ, K., PITTMAN, Q.J., GUGLIELMOTTI, V., DAVISON, J.S., DI MARZO, V., (2007) Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret. Eur J Neurosci. 25(9):2773-2782

44. SPENCER, S.J., MOUIHATE, A., PITTMAN Q.J. (2007) Peripheral inflammation exacerbates damage after global ischemia independently of temperature and acute brain inflammation. Stroke. 38(5):1570-1577

45. GILLARD, E.R., COBURN, C.G., DE LEON, A., SNISSARENKO, E.P., BAUCE L.G., PITTMAN Q.J., HOU, B., CURRAS-COLLAZO, M.C. (2007) Vasopressin autoreceptors and nitric oxide-dependent glutamate release are required for somatodendritic vasopressin release from rat magnocellular neuroendocrine cells responding to osmotic stimuli. Endocrinology. 148(2):479-89

46. SPENCER, S.J., HYLAND N.P., SHARKEY, K.A., PITTMAN Q.J. (2007) Neonatal immune challenge exacerbates experimental colitis in adult rats: potential role for TNFα. Am J Physiol Regul Integr Comp Physiol. 292(1):R308-315

47. MOUIHATE, A, HORN, T.F., PITTMAN, Q.J. (2006) Oxyresveratrol dampens neuroimmune response in vivo: a selective effect of TNFα. Am J Physiol Regul Integr Comp Physiol. 291(5): R1215-1221.

48. KOZORIZ, M.G., KUZMISKI, J.B., HIRASAWA, M., PITTMAN, Q.J. (2006) Galanin modulates neuronal and synaptic properties in the rat supraoptic nucleus in a use and state dependent manner. J Neurophysiol. 96(1):154-164

49. ELLIS, S., MOUIHATE, A., PITTMAN, Q.J. (2006) Neonatal programming of the rat neuroimmune response: stimulus specific changes elicited by bacterial and viral mimetics. J Physiol. 571.3:695-701.

50. HARRÉ, E.-M., MOUIHATE, A., PITTMAN, Q.J. (2006) Attenuation of fever at near term: is interleukin-6-STAT3 signalling altered? J Neuroendocrinol.18 (1):57-63.

51. GILLARD, E.R., LEON-OLEA, M., MUCIO-RAMIREZ, S., COBURN, C.G., SANCHEZ-ISLAS, E., DE LEON, A., MUSSENDEN, H., BAUCE, L.G., PITTMAN, Q.J., CURRAS-COLLAZO, M.C. (2006) A novel role for endogenous pituitary adenylate cyclase activating polypeptide in the magnocellular neuroendocrine system. Endocrinology. 147(2):791-803

52. CHAMBERS, A.P., KOOPMANS, H.S., PITTMAN, Q.J., SHARKEY, K.A. (2006) AM 251 produces sustained reductions in food intake and body weight that are resistant to tolerance and conditioned taste aversion. Br J Pharmacol.147(1):109-116

53. SPENCER, S.J., MARTIN, S., MOUIHATE, A., PITTMAN, Q.J. (2006) Early-life immune challenge: defining a critical window for effects on adult responses to immune challenge. Neuropsychopharmacology. 31(9):1910-1918.


21

54. SPENCER, S.J., AUER, R.N., PITTMAN, Q.J. (2006) Rat neonatal immune challenge alters adult responses to cerebral ischaemia. J Cereb Blood Flow Metab. 26(4):456-467

55. SPENCER, S.J., BOISSE, L., MOUIHATE, A., PITTMAN, Q.J. (2006) Long term alterations in neuroimmune responses of female rats after neonatal exposure to lipopolysaccharide. Brain Behav Immun. 20(4):325-330.

56. HEIDA, J.G., TESKEY, G.C., PITTMAN, Q.J. (2005) Febrile convulsions induced by the combination of lipopolysaccharide and low-dose kainic acid enhance seizure susceptibility, not epileptogenesis, in rats. Epilepsia. 46(12):1898-1905.

57. HEIDA, J.G., PITTMAN, Q.J. (2005) Causal links between brain cytokines and experimental febrile convulsions in the rat. Epilepsia. 46(12):1906-1913.

58. BOISSE, L., SPENCER, S.J., MOUIHATE, A., VERGNOLLE, N., PITTMAN, Q.J. (2005) Neonatal immune challenge alters nociception in the adult rat. Pain. 119(1-3):133-141.

59. MOUIHATE, A., ELLIS, S., HARRE, E.M., PITTMAN, Q.J. (2005) Fever suppression in near-term pregnant rats is dissociated from LPS-activated signaling pathwaysAm J Physiol Regul Integr Comp Physiol. 289(5):R1265-1272.

60. SPENCER, S.J., HEIDA, J.G., PITTMAN, Q.J. (2005) Early life immune challenge-effects on behavioural indices of adult rat fear and anxiety. Behav Brain Res. 164(2):231-238.

61. VAN SICKLE, M.D., DUNCAN, M., KINGSLEY, P.J., MOUIHATE, A., URBANI, P., MACKIE, K., STELLA, N., MAKRIYANNIS, A., PIOMELLI, D., DAVISON, J.S., MARNETT, L.J., DI MARZO, V., PITTMAN, Q.J., PATEL, K.D., SHARKEY, K.A. (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science. 310(5746):329-332.

62. ELLIS, S., MOUIHATE, A., PITTMAN, Q.J. (2005) Early life immune challenge alters innate immune responses to lipopolysaccharide: implications for host defense as adults. FASEB J, 19(11):1519-1521

63. NATAH, S.S., MOUIHATE, A., PITTMAN, Q.J., SHARKEY, K.A. (2005) Disruption of the blood-brain barrier during TNBS colitis. Neurogastroenterol Motil. 17(3):433-446

64. MATHISON, R., HO, W., PITTMAN, Q.J., DAVISON, J.S., SHARKEY, K.A. (2004) Effects of cannabinoid receptor-2 activation on accelerated gastrointestinal transit in lipopolysaccharide-treated rats. Br J Pharmacol. 142(8):1247-1254

65. HIRASAWA, M., SCHWAB, Y., NATAH, S., HILLARD, C.J., MACKIE, K., SHARKEY, K.A., PITTMAN, Q.J. (2004) Dendritically released transmitters cooperate via autocrine and retrograde actions to inhibit afferent excitation in rat brain. J Physiol, 559.2:611-624.

66. ANDERSON, T. HU, B., PITTMAN, Q., KISS, Z.H. (2004) Mechanisms of deep brain stimulation: an intracellular study in rat thalamus. JPhysiol, 559.1:301-313.

67. HEIDA, J.G., BOISSE, L., PITTMAN, Q.J. (2004) Lipopolysaccharide induced febrile convulsions in the rat: short-term sequelae. Epilepsia. 45(11):1317-1329


22

68. BOISSE, L., MOUIHATE, A., ELLIS, S., PITTMAN, Q.J. (2004) Long-Term Alterations in Neuroimmune Responses after Neonatal Exposure to lipopolysaccharide. J Neurosci, 24(21):4928-4934.

69. MOUIHATE, A., BOISSE, L., PITTMAN, Q.J. (2004) A novel antipyretic action of 15-deoxy-Delta 12, 14-prostaglandin J2 in the rat brain. J Neurosci, 24(6):1312-1318

70. PEARSON, S.A., MOUIHATE, A., PITTMAN, Q.J., WHELAN, P.J. (2003) Peptidergic activation of locomotor pattern generators in the neonatal spinal cord. J Neuroscience, 23(31):10154-10163

71. MOUIHATE, A., PITTMAN, Q.J. (2003) Neuroimmune response to endogenous and exogenous pyrogens is differently modulated by sex steroids. Endocrinology. 144(6):2454-2460.

72. HIRASAWA, M., PITTMAN, Q.J. (2003) Nifedipine facilitates neurotransmitter release independently of calcium channels. Proc Natl Acad Sci. 100(10):6139-6144.

73. HIRASAWA, M., MOUGINOT, D., KOZORIZ, M.G., KOMBIAN, S.B., PITTMAN, Q.J. (2003) Vasopressin differentially modulates non-NMDA receptors in vasopressin and oxytocin neurons in the supraoptic nucleus. J Neuroscience, 23(10):4270-4277.

74. BOISSÉ, L., VAN SICKLE, M.D., SHARKEY, K.A., PITTMAN, Q.J. (2003) Compromised neuroimmune status in rats with experimental colitis. J Physiol, 548.3:929-939.

75. CLERGET-FROIDEVAUX, M.S., PITTMAN, Q.J. (2003) AVP V 1a -R expression in the rat hypothalamus around paturition: relevance to antipyresis at term. Exp Neurol, 183(2):338-345.

76. IVANOV, A.I., ROMANOVSKY, A.A., MATSUMURA, K., MOUIHATE, A., CLERGET-FROIDEVAUX, M.S., WALLACE, J.L., PITTMAN, Q.J. (2003) Near-term suppression of fever: inhibited synthesis or accelerated catabolism of prostaglandin E2? Am J Physiol Regul Integr Comp Physiol, 284(3):R860-5.

77. MOUIHATE, A., CLERGET-FROIDEVAUX, M-S., NAKAMURA, K., NEGISHI, M., WALLACE, J.L., PITTMAN, Q.J. (2002) Suppression of fever at near term is associated with reduced COX-2 protein expression in rat hypothalamus. Am J Physiol Regul Integr Comp Physiol, 283(3):R800-805.

78. KOMBIAN, S.B., HIRASAWA, M., MATOWE, W.C., PITTMAN, Q.J. (2001) GABAB receptors modulate short-term potentiation of spontaneous excitatory postsynaptic currents in the rat supraoptic nucleus in vitro. Neuropharmacology. 41(5):554-564.

79. PRICE, C.J., PITTMAN, Q.J. (2001) Dopamine D4 receptor activation inhibits presynaptically glutamatergic neurotransmission in the rat supraoptic nucleus.J Neurophysiol. 86(3):1149-1155.

80. HIRASAWA, M., KOMBIAN, S.B., PITTMAN, Q.J. (2001) Oxytocin retrogradely inhibits evoked, but not miniature EPSCs in the rat supraoptic nucleus: role of N- and P/Q-type calcium channels. J Physiol. 532.3:595-607.


23

81. DONG, H., MOODY-CORBETT, F., COLBOURNE, F., PITTMAN, Q., CORBETT, D. (2001) Electrophysiological properties of CA1 neurons protected by postischemic hypothermia in gerbils. Stroke. 32(3):788-795.

82. MARTIN, S.M., WILSON, B.C., CHEN, X., TAKAHASHI, Y., POULIN, P., PITTMAN, Q.J. (2000) Vagal CCK and 5-HT3 receptors are unlikely to mediate LPS or IL-1ß-induced fever. Am J Physiol: Regul Integr Comp Physiol. 279(3):R960-965.

83. KIROUAC, G.J., PITTMAN, Q.J. (2000) A projection from the ventral tegmental area to the periaqueductal gray involved in cardiovascular regulation. Am J Physiol: Regul Integr Comp Physiol. 278(6):R1643-1650.

84. MCCULLOUGH, L.K., TAKAHASHI, Y., LE, T., PITTMAN, Q.J., SWAIN, M.G. (2000) Attenuated febrile response to lipopolysaccharide in rats with biliary obstruction. Am J Physiol: Gastrointest Liver Physiol. 279(1):G172-177.

85. KOMBIAN, S.B., HIRASAWA, M., MOUGINOT, D., CHEN, X., PITTMAN, Q.J. (2000) Short-term potentiation of miniature excitatory synaptic currents causes excitation of supraoptic neurons. J Neurophysiol. 83(5):2542-2553.

86. KOMBIAN, S.B., MOUGINOT, D., HIRASAWA, M., PITTMAN, Q.J. (2000) Vasopressin preferentially depresses excitatory over inhibitory synaptic transmission in the rat supraoptic nucleus in vitro. J Neuroendocrinol.12(4):361-367.

87. CHEN, X., PITTMAN, Q.J. (1999) Vasopressin and amastatin induce V1-receptor-mediated suppression of excitatory transmission in the rat parabrachial nucleus.J Neurophysiol. 82(4):1689-1696.

88. CHEN, X., HIRASAWA, M., TAKAHASHI, Y., LANDGRAF, R., PITTMAN, Q.J. (1999) Suppression of PGE2 fever at near term: reduced thermogenesis but not enhanced vasopressin antipyresis. Am J Physiol. 277:R354-361.

89. KIROUAC, G.J., PITTMAN, Q.J. (1999) Identification of barosensitive neurons in the mediobasal forebrain using juxtacellular labeling. Am J Physiol. 276:R1766-1771.

90. CHEN, X., KOMBIAN, S.B., ZIDICHOUSKI, J.A., PITTMAN, Q.J. (1999) Dopamine depresses glutamatergic synaptic transmission in the rat parabrachial nucleus in vitro. Neuroscience. 90(2):457-468.

91. MOUIHATE, A., CHEN, X., PITTMAN, Q.J. (1998) Interleukin-1beta fever in rats: gender difference and estrous cycle influence. Am J Physiol. 275:R1450-1454.

92. MOUIHATE, A., PITTMAN, Q.J. (1998) Lipopolysaccharide-induced fever is dissociated from apoptotic cell death in the rat brain. Brain Res. 805(1-2):95-103.

93. MOUGINOT, D., KOMBIAN, S.B., PITTMAN, Q.J. (1998) Activation of presynaptic GABAB receptors inhibits evoked IPSCs in rat magnocellular neurons in vitro. J Neurophysiol. 79(3):1508-1517.

94. TAKAHASHI, Y., SMITH, P., FERGUSON, A.V., PITTMAN, Q.J. (1997) Circumventricular organs and fever. Am J Physiol. 273:R1690-1695.


24

95. KOMBIAN, S.B., MOUGINOT, D., PITTMAN, Q.J. (1997) Dendritically released peptides act as retrograde modulators of afferent excitation in the supraoptic nucleus in vitro. Neuron. 19(4):903-912.

96. SALEH, T.M., BAUCE, L.G., PITTMAN, Q.J. (1997) Glutamate release in parabrachial nucleus and baroreflex alterations after vagal afferent activation. Am J Physiol. 272:R1631-1640.

97. KOMBIAN, S.B., SALEH, T.M., FIAGBE, N.I., CHEN, X., AKABUTU, J.J., BOULAMWINI, J.K., PITTMAN, Q.J. (1997) Ibogaine and a total alkaloidal extract of Voacanga africana modulate neuronal excitability and synaptic transmission in the rat parabrachial nucleus in vitro. Brain Res Bull. 44(5):603-610.

98. CHEN, X., LANDGRAF, R., PITTMAN, Q.J. (1997) Differential ventral septal vasopressin release is associated with sexual dimorphism in PGE2 fever. Am J Physiol. 272:R1664-1669.

99. SALEH, T.M., KOMBIAN, S.B., ZIDICHOUSKI, J.A., PITTMAN, Q.J. (1997) Cholecystokinin and neurotensin inversely modulate excitatory synaptic transmission in the parabrachial nucleus in vitro. Neuroscience. 77(1):23-35.

100. SALEH, T.M., KOMBIAN, S.B., ZIDICHOUSKI, J.A., PITTMAN, Q.J. (1996) Peptidergic modulation of synaptic transmission in the parabrachial nucleus in vitro: importance of degradative enzymes in regulating synaptic efficacy. J Neurosci. 16(19):6046-6055.

101. KOMBIAN, S.B., ZIDICHOUSKI, J.A., PITTMAN, Q.J. (1996) GABAB receptors presynaptically modulate excitatory synaptic transmission in the rat supraoptic nucleus in vitro. J Neurophysiol. 76(2):1166-1179.

102. NEUMANN, I., DOUGLAS, A.J., PITTMAN, Q.J., RUSSELL, J.A., LANDGRAF, R. (1996) Oxytocin released within the supraoptic nucleus of the rat brain by positive feedback action is involved in parturition related events. J Neuroendocrinol. 8(3):227-233

103. MARTIN, S.M., MALKINSON, T.J., VEALE, W.L., PITTMAN, Q.J. (1996) Prostaglandin fever in rats throughout the estrous cycle, late pregnancy and post parturition. J Neuroendocrinol. 8(2):145-151.

104. NEUMANN, I., KREMARIK, P., PITTMAN, Q.J. (1995) Acute, sequence-specific effects of oxytocin and vasopressin antisense oligonucleotides on neuronal responses. Neuroscience. 69(4):997-1003.

105. POULIN, P., SZOT, P., DORSA, D.M., PITTMAN, Q.J. (1995) Vasopressin-induced sensitization: involvement of neurohypophysial peptide receptors. Eur J Pharmacol. 294(1):29-39.

106. KREMARIK, P., FREUND-MERCIER, M.J., PITTMAN, Q.J. (1995) Fundus striatum vasopressin receptors in blood pressure control. Am J Physiol. 269:R497-503


25

107. WILKINSON, M.F., PITTMAN, Q.J. (1995) Changes in arterial blood pressure alter activity of electrophysiologically identified single units of the bed nucleus of the stria terminalis. Neuroscience. 64(3):835-844.

108. NEUMANN, I., LANDGRAF, R., BAUCE, L., PITTMAN, Q.J. (1995) Osmotic responsiveness and cross talk involving oxytocin, but not vasopressin or amino acids between the supraoptic nuclei in virgin and lactating rats. J Neurosci. 15:3408-3417.

109. MARTIN, S.M., MALKINSON, T.J., VEALE, W.L., PITTMAN, Q.J. (1995) Fever in pregnant, parturient and lactating rats. Am J Physiol. 268:R919-923.

110. LANDGRAF, R., NEUMANN, I., HOLSBOER, F., PITTMAN, Q.J. (1995) Interleukin-1beta stimulates both central and peripheral release of vasopressin and oxytocin in the rat. Eur J Neurosci. 7(4):592-598.

111. BAGDAN, B., PITTMAN, Q.J. (1995) Responses of electrophysiologically identified rat paraventricular neurons to cholecystokinin and other stimuli. Neuroscience. 65(3):869-878.

112. HORN, T., BAUCE, L., LANDGRAF, R., PITTMAN, Q.J. (1995) Microdialysis with high NaCl causes central release of amino acids and dopamine. J Neurochem. 64(4):1632-1644.

113. EARLE, M.L., PITTMAN, Q.J. (1995) Involvement of the PVN and BST in 1K1C hypertension in the rat. Brain Res. 669(1):41-47.

114. NEUMANN, I., LANDGRAF, R., TAKAHASHI, Y., PITTMAN, Q.J., RUSSELL, J.A. (1994) Stimulation of oxytocin release within the supraoptic nucleus and into blood by CCK-8. Am J Physiol. 267:R1626-1631.

115. WILKINSON, M.F., HORN, T.F., KASTING, N.W., PITTMAN, Q.J. (1994) Central interleukin-1 beta stimulation of vasopressin release into the rat brain: activation of an antipyretic pathway. J Physiol. 481.3:641-646.

116. KOMAROMI, I., MALKINSON, T.J, VEALE, W.L., ROSENBAUM, G., COOPER, K.E., PITTMAN, Q.J. (1994) Effect of potassium-induced cortical spreading depression on prostaglandin-induced fever in conscious and urethane-anaesthetized rats. Can J Physiol Pharmacol. 72(7):716-721.

117. EARLE, M.L., HORN, T., KASTING, N.W., LANDGRAF, R., PITTMAN, Q.J. (1994) Lack of fever suppression or central AVP release in 1K1C hypertensive rats. Brain Res. 658:15-20.

118. NEUMANN, I., PORTER, D.W., LANDGRAF, R., PITTMAN, Q.J. (1994) Rapid effect on suckling of an oxytocin antisense oligonucleotide administered into the rat supraoptic nucleus. Am J Physiol. 267:R852-858.

119. WILKINSON, M.F., PITTMAN, Q.J. (1994) Alteration of the physiological responses to indomethacin by endotoxin tolerance in the rat: a possible role for central vasopressin. J Physiol. 479.3:441-449.


26

120. HORN, T., WILKINSON, M.F., LANDGRAF, R., PITTMAN, Q.J. (1994) Reduced febrile responses to pyrogens following lesions of the hypothalamic paraventricular nucleus. Am J Physiol. 267:R323-328.

121. HORN, T., SMITH, P.M., MCLAUGHLIN, B.E., BAUCE, L., MARKS, G.S., PITTMAN, Q.J., FERGUSON, A.V. (1994) Nitric Oxide actions in paraventricular nucleus: Cardiovascular and neurochemical implications. Am J Physiol. 266:R306-313.

122. BLUTHE, R.M., PAWLOWSKI, M., SUAREZ, S., PARNET, P., PITTMAN, Q.J., KELLEY, K.W., DANTZER, R. (1994) Synergy between tumor necrosis factor α and interleukin-1 in the induction of sickness behaviour in mice. Psychoneuroendocrinology. 19(2):197-207.

123. POULIN, P., KOMULAINEN, A., TAKAHASHI, Y., PITTMAN, Q.J. (1994) Enhanced pressor responses to ICV vasopressin after pre-treatment with oxytocin. Am J Physiol. 266:R592-598.

124. NEUMANN, I., LUDWIG, M., ENGELMANN, M., PITTMAN, Q.J., LANDGRAF, R. (1993) Simultaneous microdialysis in blood and brain: oxytocin and vasopressin release in response to central and peripheral osmotic stimulation and suckling in the rat. Neuroendocrinol. 58(6):637-645

125. WILKINSON, M.F., MATHISON, W.B., PITTMAN, Q.J. (1993) Interleukin-1 beta has excitatory effects on neurons of the bed nucleus of the stria terminalis. Brain Res. 625(2):342-346.

126. MUDRICK-DONNON, L.A., WILLIAMS, P.J., PITTMAN, Q.J., MACVICAR, B.A. (1993) Postsynaptic potentials mediated by GABA and dopamine evoked in stellate glial cells of the pituitary pars intermedia. J Neurosci. 13(11):4660-4668

127. WILLIAMS, P.J., PITTMAN, Q.J., MACVICAR, B.A. (1993) Blockade by funnel web toxin of a calcium current in the intermediate pituitary of a rat. Neurosci Lett. 157(2):171-174

128. POULIN, P., PITTMAN, Q.J. (1993) Possible involvement of brain oxytocin in modulating vasopressin antipyretic action. Am J Physiol. 265:R151-156.

129. POULIN, P., PITTMAN, Q.J. (1993) Arginine vasopressin (AVP)-induced sensitization in brain: facilitated inositol phosphate production without changes in receptor number. J Neuroendocrinol. 5(1):23-31.

130. POULIN, P., PITTMAN, Q.J. (1993) Oxytocin pre-treatment enhances AVP-induced motor disturbances and AVP-induced phosphoinositol hydrolysis in rat septum: A cross-sensitization phenomenon J Neuroendocrinol. 5(1):33-39.

131. MONDA, M., PITTMAN, Q.J. (1993) Cortical spreading depression blocks prostaglandin E1 and endotoxin fever in rat. Am J Physiol. 264:R456-459.

132. FYDA, D., VEALE, W.L., PITTMAN, Q.J. (1993) Suppression by central AVP of prostaglandin E 1 hyperthermia in one kidney one-clip Goldblatt hypertensive rats. Am J Physiol. 264:R143-148

133. WILLCOX, B.J., POULIN, P., VEALE, W.L., PITTMAN, Q.J. (1992) Vasopressin-induced motor effects: localization of a sensitive site in the amygdala. Brain Res. 596(1-2):58-64.


27

134. FEDERICO, P., MALKINSON, T.J., COOPER, K.E., PITTMAN, Q.J., VEALE, W.L. (1992) Vasopressin perfusion within the medial amygdaloid nucleus attenuates prostaglandin fever in the urethane-anaesthetized rat. Brain Res. 587(2):319-326.

135. FEDERICO, P., VEALE, W.L., PITTMAN, Q.J. (1992) Vasopressin-induced antipyresis in the medial amygdaloid nucleus of conscious rats. Am J Physiol. 262:R901-908.

136. PITTMAN, Q.J., WILKINSON, M.F. (1992) Central arginine vasopressin and endogenous antipyresis. Can J Physiol Pharmacol. 70(5):786-790.

137. WILLIAMS, P.J., PITTMAN, Q.J., MACVICAR, B.A. (1991) Ca++- and voltage dependent inactivation of Ca++ currents in rat intermediate pituitary. Brain Res. 564(1):12-18.

138. POULIN, P., PITTMAN, Q.J. (1991) Septal arginine vasopressin (AVP) receptor regulation in rats depleted of septal AVP following long-term castration. J Neurosci. 11(6):1531-1539.

139. BURNARD, D.M., PITTMAN, Q.J., MACVICAR, B.A. (1991) Neurotransmitter- mediated changes in the electrophysiological properties of pituicytes. J Neuroendocrinol. 3(4):433-439

140. LANDGRAF, R., NEUMANN, I., PITTMAN, Q.J. (1991) Septal and hippocampal release of vasopressin and oxytocin during late pregnancy and parturition in the rat. Neuroendocrinology. 54(4):378-383

141. THORNHILL, J., GREGOR, L., PITTMAN, Q.J. (1990) Pressor responses in rats following intravenous dynorphin A(1-13) administration are blocked by AVP-V1 receptor antagonism. Regul Pept. 31(1):1-10.

142. LANDGRAF, R., MALKINSON, T.J., VEALE, W.L., LEDERIS, K., PITTMAN, Q.J. (1990) Vasopressin and oxytocin in rat brain in response to prostaglandin fever. Am J Physiol. 259:R1056-R1062.

143. MARTIN, S.M., MALKINSON, T.J., VEALE, W.L., PITTMAN, Q.J. (1990) Depletion of brain -MSH alters prostaglandin and interleukin fever in rats. Brain Res. 526(2):351-354.

144. LANDGRAF, R., MALKINSON, T., HORN, T., VEALE, W.L., LEDERIS, K., PITTMAN, Q.J. (1990) Release of vasopressin and oxytocin by paraventricular stimulation in rats. Am J Physiol. 258:R155-R159.

145. THORNHILL, J.A., PITTMAN, Q.J. (1990) Hemodynamic responses of conscious rats following intrathecal injections of prodynorphin-derived opioids: independence of action of intrathecal arginine vasopressin. Can J Physiol Pharmacol. 68(2):174-182

146. WILLIAMS, P.J., MACVICAR, B.A., PITTMAN, Q.J. (1990) Synaptic modulation by dopamine of calcium currents in rat pars intermedia. J Neurosci. 10(3):757-763.

147. WILLIAMS, P.J., MACVICAR, B.A., PITTMAN, Q.J. (1990) Electrophysiological properties of neuroendocrine cells of the intact rat pars intermedia: multiple calcium currents. J Neurosci. 10(3):748-756.


28

148. COLMERS, W.F., PITTMAN, Q.J. (1989) Presynaptic inhibition by neuropeptide Y and baclofen in hippocampus: insensitivity to pertussis toxin treatment. Brain Res. 498(1):99-104

149. THORNHILL, J.A., GREGOR, L., MATHISON, R., PITTMAN, Q.J. (1989) Intrathecal dynorphin A administration causes pressor responses in rats associated with an increased resistance to spinal cord blood flow. Brain Res. 490(1):174-177.

150. RIPHAGEN, C.L., PITTMAN, Q.J. (1989) Mechanisms underlying the cardiovascular responses to intrathecal vasopressin administration in rats. Can J Physiol Pharmacol. 67(4):269-275

151. WILLIAMS, P.J., MACVICAR, B.A., PITTMAN, Q.J. (1989) A dopaminergic inhibitory postsynaptic potential mediated by an increased potassium conductance. Neuroscience. 31(3):673-681.

152. MATHIESON, W.B., FEDERICO, P., VEALE, W.L., PITTMAN, Q.J. (1989) Single unit activity in the bed nucleus of the stria terminalis during fever. Brain Res. 486(1):49-55.

153. RIPHAGEN, C.L., PITTMAN, Q.J. (1989) Spinal arginine vasopressin elevates renal nerve activity in the rat. J Neuroendocrinol. 1(5):339-344.

154. WILLIAMS, P.J., MACVICAR, B.A., PITTMAN, Q.J. (1989) Identification of a GABA-activated chloride mediated synaptic potential in rat pars intermedia. Brain Res. 483(1):130-134.

155. COLMERS, W.F., LUKOWIAK, K., PITTMAN, Q.J. (1988) Neuropeptide Y action in the rat hippocampal slice: site and mechanism of presynaptic inhibition. J Neurosci.8(10) 3827-3837.

156. WATSON, T.W., PITTMAN, Q.J. (1988) Pharmacological evidence that somatostatin activates the m-current in hippocampal pyramidal neurons. Neurosci Lett. 91(2):172-176

157. MARTIN, S.M., MALKINSON, T.J., BAUCE, L.G., VEALE, W.L., PITTMAN, Q.J. (1988) Plasma catecholamines in conscious rabbits after administration of vasopressin.Brain Res. 457(1):192-195.

158. MARTIN, S.M., MALKINSON, T.J., VEALE, W.L., PITTMAN, Q.J. (1988) Prostaglandin fever in rats is altered by kainic acid lesions of the ventral septal area. Brain Res. 455(1):196-200.

159. PITTMAN, Q.J., NAYLOR, A., POULIN, P., DISTURNAL, J., VEALE, W.L., MARTIN, S.M., MALKINSON, T.J., MATHIESON, B. (1988) The role of vasopressin as an antipyretic agent in the ventral septal area and its possible involvement in convulsive disorders. Brain Res Bull. 20(6):887-892.

160. WATSON, T.W., PITTMAN, Q.J. (1988) Somatostatin(14) and -(28), but not somatostatin(1-12) hyperpolarize CA1 pyramidal neurons in vitro. Brain Res. 448(1):40-45.

161. POULIN, P., LEDERIS, K., PITTMAN, Q.J. (1988) Subcellular localization and characterization of vasopressin binding sites in the ventral septal area, lateral septum and hippocampus of the rat brain. J Neurochem. 50(3):889-898.


29

162. FRANKLIN, L., BAUCE, L., PITTMAN, Q.J. (1988) Depletion of central catecholamines reduces pressor responses to arginine vasopressin. Brain Res. 438(1-2):295-298.

163. NAYLOR, A.M., PITTMAN, Q.J., VEALE, W.L. (1988) Stimulation of vasopressin release in the ventral septum of the rat brain suppresses prostaglandin-E1 fever. J Physiol. 399:177-189.

164. PITTMAN, Q.J., MALKINSON, T.J., KASTING, N.W., VEALE, W.L. (1988) Enhanced fever following castration: possible involvement of brain arginine vasopressin.Am J Physiol. 254:R513-R517.

165. COLMERS, W.F., LUKOWIAK, K., PITTMAN, Q.J. (1987) Presynaptic action of neuropeptide Y in area CA1 of the rat hippocampal slice. J Physiol. 383:285-299.

166. BURNARD, D.M., VEALE, W.L., PITTMAN, Q.J. (1987) Altered sensitivity to arginine vasopressin (AVP) in area CA1 of the hippocampal slice following pre-treatment of rats with AVP. Brain Res. 422(1):11-16.

167. SIGGINS, G.R., PITTMAN, Q.J., FRENCH, E.D. (1987) Effects of ethanol on CA1 and CA3 pyramidal cells in the hippocampal slice preparation: an intracellular study. Brain Res. 414(1):22-34.

168. DISTURNAL, J.E., VEALE, W.L., PITTMAN, Q.J. (1987) Modulation by arginine-vasopressin of glutamate excitation in the ventral septal area of the rat brain. Can J Physiol Pharmacol. 65(1):30-35

169. RIPHAGEN, C.L., PITTMAN, Q.J. (1986) Oxytocin and [1-deamino, 8-D-arginine]-vasopressin (dDAVP): intrathecal effects on blood pressure, heart rate and urine output. Brain Res. 374(2):371-374.

170. DISTURNAL, J.E., VEALE, W.L., PITTMAN, Q.J. (1986) The ventral septal area: electro-physiological evidence for putative arginine vasopressin projections onto thermoresponsive neurons. Neuroscience. 19(3):795-802.

171. RIPHAGEN, C.L., BAUCE, L., VEALE, W.L., PITTMAN, Q.J. (1986) The effects of intrathecal administration of arginine-vasopressin and substance P on blood pressure and adrenal secretion of epinephrine in rats. J Auton Nerv Syst. 16(2):91-99.

172. MACVICAR, B.A., PITTMAN, Q.J. (1986) Novel synaptic responses mediated by dopamine and gamma-aminobutyric acid in neuroendocrine cells of the intermediate pituitary. Neurosci Lett. 64(1):35-40

173. RIPHAGEN, C.L., PITTMAN, Q.J. (1986) Arginine vasopressin as a central neurotransmitter. Fed Proc. 45(9):2318-2322.

174. BURNARD, D.M., VEALE, W.L., PITTMAN, Q.J. (1986) Prevention of arginine vasopressin-induced motor disturbances by a potent vasopressor antagonist. Brain Res. 362(1):40-46.


30

175. RUWE, W.D., BAUCE, L., FLEMONS, W.W., VEALE, W.L., PITTMAN, Q.J. (1986) Alcohol dependence and withdrawal in the rat. An effective means of induction and assessment. J Pharmacol Methods. 15(3):225-234.

176. LAWRENCE, D., PITTMAN, Q.J. (1985) Interaction between descending paraventricular neurons and vagal motor neurons. Brain Res. 332(1):158-160.

177. COLMERS, W.F., LUKOWIAK, K., PITTMAN, Q.J. (1985) Neuropeptide Y reduces orthodromically-evoked population spike in rat hippocampal CA1 by a possibly presynaptic mechanism. Brain Res. 346(2):404-408.

178. DISTURNAL, J.E., VEALE, W.L., PITTMAN, Q.J. (1985) Electrophysiological analysis of potential arginine vasopressin projections to the ventral septal area of the rat.Brain Res. 342(1):162-167.

179. NAYLOR, A.M., RUWE, W.D., BURNARD, D.M., MCNEELY, P.D., TURNER, S.L., PITTMAN, Q.J., VEALE, W.L. (1985) Vasopressin-induced motor disturbances: localization of a sensitive forebrain site in the rat. Brain Res. 361:242-246

180. PITTMAN, Q.J., FRANKLIN, L.G. (1985) Vasopressin antagonist in nucleus tractus solitarius/vagal area reduces pressor and tachycardia responses to paraventricular nucleus stimulation in rats. Neurosci Lett. 56(2):155-160.

181. MARTIN, S.M., MALKINSON, T.J., VEALE, W.L., PITTMAN, Q.J. (1985) The action of centrally administered arginine vasopressin on blood pressure in the conscious rabbit. Brain Res. 348(1):137-145.

182. RUWE, W.D., FLEMONS, W.W., VEALE, W.L., PITTMAN, Q.J. (1985) The role of arginine vasopressin in alcohol dependence and withdrawal. Peptides. 6(6):1043-1049.

183. RIPHAGEN, C.L., PITTMAN, Q.J. (1985) Cardiovascular responses to intrathecal administration of arginine vasopressin in rats. Regul Pept. 10(4):293-298.

184. RIPHAGEN, C.L., PITTMAN, Q.J. (1985) Vasopressin influences renal function via a spinal action. Brain Res. 336(2):346-349

185. LAWRENCE, D., PITTMAN, Q.J. (1985) Response of rat paraventricular neurons with central projections to suckling, haemorrhage or osmotic stimuli. Brain Res. 341(1):176-183.

186. LAWRENCE, D., PITTMAN, Q.J. (1985) Lack of "sensitization" to the pressor effects of centrally injected vasopressin in rats. Brain Res. 334(1):157-159.

187. BURNARD, D.M., PITTMAN, Q.J., VEALE, W.L. (1985) Brattleboro rats display increased sensitivity to arginine vasopressin-induced motor disturbances. Brain Res. 342(2):316-322.

188. SIGGINS, G.R., GRUOL, D., ALDENHOFF, J., PITTMAN, Q.J. (1985) Electrophysiological actions of corticotrophin releasing factor in the central nervous system. Fed Proc. 44:237-242.


31

189. CIRIELLO, J., LAWRENCE, D., PITTMAN, Q.J. (1984) Electrophysiological identification of neurons in the parabrachial nucleus projecting directly to the hypothalamus in the rat. Brain Res. 322(2):388-392.

190. FERGUSON, A.V., PITTMAN, Q.J., RIPHAGEN, C.L. (1984) Effect of cooling on supraoptic neurohypophysial neuronal activity and on urine flow in the rat. J Physiol. 352:103-112.

191. PITTMAN, Q.J., RIPHAGEN, C.L., LEDERIS, K. (1984) Release of immunoassayable neurohypophysial peptides from rat spinal cord, in vivo. Brain Res. 300(2):321-326.

192. PITTMAN, Q.J. (1983) Increases in antidromic latency of neurohypophysial neurons during sustained activation. Neurosci Lett. 37(3):239-243.

193. BURNARD, D.M., PITTMAN, Q.J., VEALE, W.L. (1983) Increased motor disturbances in response to arginine vasopressin following hemorrhage or hypertonic saline: evidence for central AVP release in rats. Brain Res. 273(1):59-65.

194. BLUME, H.W., PITTMAN, Q.J., LAFONTAINE, S., RENAUD, L.P. (1982) Lateral septum-medial hypothalamic connections: an electrophysiological study in the rat. Neuroscience. 7(11):2783-2792.

195. PITTMAN, Q.J., ROGERS, J., BLOOM, F.E. (1982) Arginine vasopressin deficient Brattleboro rats fail to develop tolerance to the hypothermic effects of ethanol. Regul Pept. 4(1):33-41

196. PITTMAN, Q.J., VEALE, W.L., LEDERIS, K. (1982) Central neurohypophysial peptide pathways: interactions with endocrine and other autonomic functions. Peptides. 3(3):515-520.

197. PITTMAN, Q.J., LAWRENCE, D., MCLEAN, L. (1982) Central effects of arginine vasopressin on blood pressure in rats. Endocrinology. 110(3):1058-1060.

198. DARMON, M., STALLCUP, W.B., PITTMAN, Q.J. (1982) Induction of neural differentiation by serum deprivation in cultures of the embryonal carcinoma cell line 1003. Exp Cell Res. 138(1):73-78.

199. BLOOM, F.E., LAD, P.J., PITTMAN, Q.J., ROGERS, J. (1982) Blood alcohol levels in rats: non-uniform yields from intraperitoneal doses based on body weight.Brit J Pharmacol. 75(1):251-254.

200. PITTMAN, Q.J., SIGGINS, G.R. (1981) Somatostatin hyperpolarizes hippocampal pyramidal cells in vitro. Brain Res. 221(2):402-408.

201. PITTMAN, Q.J., BLUME, H.W., RENAUD, L.P. (1981) Connections of the hypothalamic paraventricular nucleus with the neurohypophysis, median eminence, amygdala, lateral septum and midbrain periaqueductal gray; an electrophysiological study in the rat.Brain Res. 215(1-2):15-28.

202. PITTMAN, Q.J., HATTON, J.D., BLOOM, F.E. (1981) Spontaneous activity in perfused hypothalamic slices: dependence on calcium content of perfusate. Exp Brain Res. 42(1):49-52


32

203. BLUME, H.W., PITTMAN, Q.J., RENAUD, L.P. (1981) Sensitivity of identified medial hypothalamic neurons to GABA, glycine and related amino acids; influence of bicuculline, picrotoxin and strychnine on synaptic inhibition. Brain Res. 209(1):145-158

204. PITTMAN, Q.J., HATTON, J.D., BLOOM, F.E. (1980) Morphine and opioid peptides reduce paraventricular neuronal activity: studies on the rat hypothalamic slice preparation. Proc Natl Acad Sci USA. 77(9):5527-5531

205. PITTMAN, Q.J., TACHE, Y., BROWN, M.R. (1980) Bombesin acts in preoptic area to produce hypothermia in rats. Life Sci. 26(9):725-730.

206. TACHE, Y., PITTMAN, Q.J., BROWN, M. (1980) Bombesin induced poikilothermy in rats. Brain Res. 188(2):525-530.

207. RENAUD, L.P., BLUME, H.W., PITTMAN, Q.J., LAMOUR, Y., TAN, A.T. (1979) Thyrotropin releasing hormone (TRH) selectively depresses glutamate excitation of cerebral cortical neurons. Science. 205(4412):1275-1277.

208. PITTMAN, Q.J., BLUME, H.W., KEARNEY, R.E., RENAUD, L.P. (1979) Influence of midbrain stimulation on the excitability of neurons in the medial hypothalamus of the rat. Brain Res. 174(1):39-53.

209. ROSSIER, J., BATTENBERG, E., PITTMAN, Q.J., BAYON, A., KODA, L., MILLER, R., GUILEMIN, R., BLOOM, F. (1979) Hypothalamic encephalin neurons may regulate neurohypophysis. Nature. 227(5698):653-655

210. PITTMAN, Q.J., BLUME, H.W., RENAUD, L.P. (1978) Electrophysiological indications that individual hypothalamic neurons innervate both median eminence and neurohypophysis. Brain Res. 157(2):364-368.

211. BLUME, H.W., PITTMAN, Q.J., RENAUD, L.P. (1978) Electrophysiological indications of a 'vasopressinergic' innervation of the median eminence. Brain Res. 155(1):153-158.

212. HARRIS, W.H., PITTMAN, Q.J., VEALE, W.L., COOPER, K.E., VAN PETTEN, G.R. (1977) Cardiovascular effects of fever in the ewe and fetal lamb. Am J Obstet Gynecol. 128(3):262-265.

213. PITTMAN, Q.J., VEALE, W.L., COOPER, K.E. (1977) Absence of fever following intra-hypothalamic injections of prostaglandins in sheep. Neuropharmacol. 16(11):743-749.

214. PITTMAN, Q.J., VEALE, W.L., COOPER, K.E. (1977) Effect of prostaglandin, pyrogen and noradrenaline, injected into the hypothalamus, on thermoregulation in the newborn lamb. Brain Res. 128(3):473-483.

215. COOPER, K.E., VEALE, W.L., PITTMAN, Q.J. (1976) Metabolic and other aspects of fever. Israel J Med Sci. 12(9):955-959.


33

216. COOPER, K.E., JONES, D.L., PITTMAN, Q.J., VEALE, W.L. (1976) The effect of noradrenaline, injected into the hypothalamus, on thermoregulation in the cat. J Physiol. 261(1):211-222.

217. COOPER, K.E., PITTMAN, Q.J., VEALE, W.L. (1976) The effect of noradrenaline and 5-hydroxytryptamine injected into a lateral cerebral ventricle, on thermoregulation in the newborn lamb. J Physiol. 261(1):223-234.

218. PITTMAN, Q.J., VEALE, W.L., COCKERAM, A.M., COOPER, K.E. (1976) Changes in body temperature produced by prostaglandins and pyrogens in the chicken.Am J Physiol. 230(5):1284-1287.

219. PITTMAN, Q.J., VEALE, W.L., COOPER, K.E. (1976) Observations on the effect of salicylate in fever and the regulation of body temperature against cold. Can J Physiol Pharmacol. 54(2):101-106

220. PITTMAN, Q.J., VEALE, W.L., COOPER, K.E. (1975) Temperature responses of lambs after centrally injected prostaglandins and pyrogens. Am J Physiol. 228(4):1034-1038.

221. PITTMAN, Q.J., COOPER, K.E., VEALE, W.L., VAN PETTEN, G.R. (1974) Observations on the development of the febrile response to pyrogens in sheep.Clin Sci Mol Med. 46(5):591-602.

222. PITTMAN, Q.J., COOPER, K.E., VEALE, W.L., VAN PETTEN, G.R. (1973) Fever in newborn lambs. Can J Physiol Pharmacol. 51(11):868-872.

REFEREED REVIEWS, BOOK CHAPTERS AND SYMPOSIUM PROCEEDINGS

1. MAZARATI, A.M., LEWIS, M.L., PITTMAN, Q.J., (2017) Neurobehavioral comorbidities of epilepsy: Role of inflammation. Epilepsia Jul;58 Suppl 3:48-56. doi: 10.1111/epi.13786

2. HARDEN, L.M., KENT, S., PITTMAN, Q.J., ROTH, J., (2015) Fever and sickness behavior: Friend or foe? Brain Behav Immun. 50:322-333

3. NYUYKI, K.D., PITTMAN, Q.J. (2015) Toward a better understanding of the central consequences of inflammation. Ann N Y Acad Sci 135:322-33

4. RANA, S.A., AAVANI, T., PITTMAN, Q.J. (2012) Sex effects on neurodevelopmental outcomes of innate immune activation during prenatal and neonatal life. Hormones and Behavior 62:228–236

5. VEZZANI, A., ARONICA, E., MAZARATI, A., PITTMAN, Q.J. (2013) Epilepsy and brain inflammation. Experimental Neurol. 244:11-21

6. GALIC, M.A., RIAZI, K., PITTMAN, Q.J. (2012) Cytokines and brain excitability. Front Neuroendocrinol. 33 (1):116-125

7. SPENCER, S.J., GALIC, M.A., PITTMAN, Q.J. (2011) Neonatal programming of innate immune function. Am J. Physiol Endocrinol Metab. 300(1):E11-18


34

8. KENTNER, A.C., PITTMAN, Q.J. (2010) Early-life programming by inflammation of the neuroendocrine system. Endocrinology. 151:4602-4606

9. BRANCO, L.G., BICEGO, K.C., CARNIO, E.C., PITTMAN, Q.J. (2010) Gaseous neurotransmitters and their role in anapyrexia. Front Biosci. 2:948-960

10. PATEL, K.D., DAVISON, J.S., PITTMAN, Q.J., SHARKEY, K.A. (2010) Cannabinoid CB(2) receptors in health and disease. Curr Med Chem. 17(14):1393-1410

11. RIAZI, K., GALIC, M.A., PITTMAN, Q.J. (2010) Contributions of peripheral inflammation to seizure susceptibility: Cytokines and brain excitability. Epilepsy Res. 89 (1):34-42

12. GALIC, M.A., SPENCER, S.J., MOUIHATE, M., PITTMAN, Q.J. (2009) Postnatal programming of the innate immune response. Integr Comp Bio. 49(3):237-245

13. REID, A.Y., GALIC, M.A., TESKEY, G.C., PITTMAN, Q.J. (2009) Febrile seizures: Current views and investigations. Can J Neurol Sci. 36:679-686

14. PITTMAN, Q.J., HOLLENBERG, M.D., (2009) Urotensin 1-CRF-urocortins: a mermaid’s tail. Gen Comp Endocrinol. 164(1):7-14

15. HEIDA, J.G., MOSHE, S.L., PITTMAN, Q.J. (2009) The role of interleukin-1beta in febrile seizures. Brain Dev. 31(5):388-393

16. MOUIHATE, A., HARRE, E.M., MARTIN, S., PITTMAN, Q.J. (2008) Suppression of the febrile response in late gestation: evidence, mechanisms and outcomes. J Neuroendocrinol. 20(4):508-514

17. SPENCER, S.J., MOUIHATE, A., GALIC, M.A., PITTMAN, Q.J. (2008) Central and peripheral neuroimmune responses: hyporesponsiveness during pregnancy. J Physiol. 586(2):399-406

18. MCDONALD, N.A., KUZMISKI J.B., NADERI, N., SCHWAB, Y., PITTMAN Q.J. (2008) Endogenous modulators of synaptic transmission: Cannabinoid regulation in the Supraoptic Nucleus. Prog Brain Res. 170:129-136

19. SHARKEY, K.A., PITTMAN, Q.J. (2005) Central and Peripheral Signaling Mechanisms Involved in Endocannabinoid Regulation of Feeding: A Perspective on the Munchies. Sci STKE. (277):pe15

20. LUDWIG, M., PITTMAN, Q.J. (2003) Talking back: Dendritic neurotransmitter release. Trends Neurosci. 26(5):255-261.

21. KOMBIAN, S.B., HIRASAWA, M., MOUGINOT, D., PITTMAN, Q.J. (2002) Modulation of synaptic transmission by oxytocin and vasopressin in the supraoptic nucleus. Prog Brain Res. 139:235-246.

22. PITTMAN, Q.J. (2002) The Autonomic Nervous System and Thermoregulation. In: Handbook of the Autonomic Nervous System in Health and Disease. (eds). C. Liana Bolis, Julio Licinio, Stefano Govoni. pp. 247-275


35

23. PITTMAN, Q.J., MOUIHATE, A., CLERGET. M.S., (2001) Fever and Antipyresis. In: Neuroimmune Biology, Vol. 1: New Foundation of Biology I. Berczi, R.M. Gorezynski (eds). Elsevier. pp. 297-305.

24. PITTMAN, Q.J., HIRASAWA, M., MOUGINOT, D., KOMBIAN, S.B. (2000) Neurohypophysial peptides as retrograde transmitters in the supraoptic nucleus of the rat. Exp. Physiol . 85S:139S-143S.

25. PITTMAN, Q.J. (1999) Peptides in the autonomic nervous system. In: The Autonomic Nervous System. C.L. Bolis and J. Licinio (eds). World Health Organization, pp. 43-52.

26. PITTMAN, Q.J., CHEN, X., MOUIHATE, A., HIRASAWA, M., MARTIN, S. (1998) Arginine vasopressin, fever and temperature regulation. In: Prog Brain Res. I.J.A. Urban, J.P.H. Burbach and D. DeWied (eds). 119:383-392.

27. PITTMAN, Q.J., CHEN, X., MOUIHATE, A., MARTIN, S. (1998) Vasopressin-induced antipyresis: sex- and experience-dependent febrile responses. Ann N Y Acad Sci. 856:53-61.

28. NEUMANN, I.D., PITTMAN, Q.J. (1998) Rapid onset of antisense effects: evidence for a close link between gene expression and neuronal activity. In: Modulating Gene Expression by Antisense Oligonucleotides to Understand Neural Functioning. M.M. McCarthy (ed), Kluwer Academic Publishers, Norwell, Massachusetts, pp. 43-59.

29. PITTMAN, Q.J., MOUGINOT, D., KOMBIAN, S.B. (1998) GABAB receptors and supraoptic neuronal activity. In: Vasopressin and Oxytocin: Molecular, Cellular and Clinical Advances. H.H. Zingg, C.W. Bourque and D.G. Bichet (eds). Plenum, New York, Adv Exp Med Biol. pp. 107-115.

30. PITTMAN, Q.J., KOMBIAN, S.B., MOUGINOT, D., CHEN, X., VAN EERDENBERG, F.J. (1998) Electrophysiological studies of neurohypophysial neurons and peptides. In: Prog Brain Res. I.J.A. Urban, J.P.H. Burbach and D. DeWied (eds). 119:311-320.

31. PITTMAN, Q.J. (1997) Hypothalamus. In: The Encyclopedia of Human Biology. 2nd Ed., Vol. 4, Dulbecco, R. (ed.) Academic Press, Inc. pp. 681-690

32. MALKINSON, T.J., PITTMAN, Q.J. (1997) Temperature treck. The next generation in data analysis. Ann N Y Acad Sci. 813:230-232.

33. SHARKEY, K.A., PITTMAN, Q.J. (1996) The Autonomic Nervous System: peripheral and central integrative aspects. In: Comprehensive Human Physiology, Vol. 1. R. Gregor and U. Windhorst (eds). Springer-Verlag, Heidelberg, Germany. pp. 335-353.

34. NEUMANN, I. PITTMAN, Q.J., LANDGRAF, R. (1995) Release of oxytocin within the supraoptic nucleus. Mechanisms, physiological significance and antisense targeting. Adv Exp Med Biol. 395:173-183

35. NEUMANN, I., PITTMAN, Q.J., LANDGRAF, R. (1995) Release of oxytocin within the supraoptic nucleus. In: Oxytocin. Ivell, R. and Russell, J. (eds). Plenum Press, New York. pp. 173-183.


36

36. NEUMANN, I., KREMARIK, P., LANDGRAF, R., PITTMAN, Q.J. (1995) Short-term effects of vasopressin and oxytocin antisense oligonucleotides on the activity of rat neurohypophysial neurons in vivo. In: Neurohypophysis: Recent Progress of Vasopressin and Oxytocin Research. Saito, T., Kurokawa, K., Yoshida, S., (eds). Elsevier Science Publishers B.V., Amsterdam, The Netherlands. pp. 113-129.

37. PITTMAN, Q.J., MARTIN, S., NEUMANN, I., WILKINSON, M.F., TAKAHASHI, Y., (1995) Central actions of arginine vasopressin to inhibit endotoxin and cytokine action. In: Neurohypophysis: Recent Progress of Vasopressin and Oxytocin Research. Saito, T., Kurokawa, K., Yoshida, S., (eds). Amsterdam. pp. 321-329.

38. WALLACE, J.L., PITTMAN, Q.J., CIRINO G. (1995) Nitric oxide-releasing NSAIDs: A novel class of GI-sparing anti-inflammatory drugs. In: Novel Molecular Approaches to Anti-Inflammatory Theory, Birkhauser Verlag Basel, pp. 121-129. (also published as Agents Actions Suppl. 46:121-129)

39. HORN, T., MALKINSON, T.J., PITTMAN, Q.J., LANDGRAF, R. (1994) Hyperosmotic stimulation of the hypothalamic paraventricular and supraoptic nuclei alters body temperature in the normothermic and febrile rat. In: Pharmacology of Thermoregulation. E. Zeisberger, P. Lomax and E. Schönbaum (eds). Birkhauser, Verlag, AG. pp. 397-402.

40. EARLE, M.L., HORN, T., KASTING, N., LANDGRAF, R., PITTMAN, Q.J. (1994) Ventral septal AVP release in the febrile hypertensive and normotensive rat. In: Pharmacology of Thermoregulation. E. Zeisberger, P. Lomax and E. Schönbaum (eds). Birkhäuser, Verlag, AG. pp. 391-396.

41. MALKINSON, T.J., COOPER, K.E., VEALE, W.L., PITTMAN, Q.J. (1994) An artificial intelligence approach to selectively search, analyze and display thermoregulatory data. In: Pharmacology of Thermoregulation. E. Zeisberger, P. Lomax and E. Schönbaum (eds). Birkhauser, Verlag, AG. pp. 133-138.

42. LANDGRAF, R., HORN, T., NEUMANN, I., PITTMAN, Q.J., LUDWIG, M. (1994) Effects of osmotic stimulation of the supraoptic nucleus on central and peripheral release of vasopressin and on baro- and thermoregulation. In: Integrative and Cellular Aspects of Autonomic Functions: Temperature and Osmoregulation. K. Pleschka and R. Gerstberger (eds). John Libbey Eurotext, Paris, pp. 419-428.

43. PITTMAN, Q.J., GOODALL, G. (1994) Hypothalamus. In: Encyclopedia of Human Behavior, Vol. 2. V.S. Ramachandran (editor). Academic Press. pp. 567-577.

44. PITTMAN, Q.J., POULIN, P., WILKINSON, M.F. (1993) Role of neurohypophysial hormones on temperature regulation. Ann N Y Acad Sci. 689:375-381

45. PITTMAN, Q.J., BAGDAN, B. (1992) Vasopressin involvement in central control of blood pressure. In: IV International Reinhardsbrun CVO Symposium - Circumventricular Organs and Brain Fluid Environment, Molecular and Functional Aspects: Progress in Brain Research. Ermich, A., Landgraf, R. and Rühle, H.J. (eds). Vol. 91. pp. 69-74.


37

46. WILKINSON, M.F., MONDA, M., KASTING, N.W., PITTMAN, Q.J. (1992) The effects of centrally administered prostaglandin E2 during pyrogenic tolerance to E. Coli endotoxin. In: Thermoregulation: The Pathophysiological Basis of Clinical Disorders. Lomax, P. and Schonbaum, E. (eds). Karger, Basel. pp. 147-151.

47. COOPER, K.E., MALKINSON, T.J., MONDA, M., PITTMAN, Q.J., VEALE, W.L. (1992) New neurobiological concepts of the genesis of fever and of antipyresis. Proc. Conf. on Immunology of Fever. Bartfai, T. and Ottoson, D. (eds). Pergamon Press, pp. 225-234.

48. LANDGRAF, R., NEUMANN, I., RUSSELL, J.A., PITTMAN, Q.J. (1992) Push-pull perfusion and microdialysis studies of central oxytocin and vasopressin release in freely moving rats during pregnancy, parturition and lactation. In: Oxytocin in Maternal, Sexual and Social Behaviors. Pedersen, C.A. (ed). Ann N Y Acad Sci. 652:326-339.

49. WILLCOX, B.J., POULIN, P., PITTMAN, Q.J., VEALE, W.L. (1992) The putative antipyretic arginine vasopressin may induce behavior through multiple sites of action. In: Thermoregulation: The Pathophysiological Basis of Clinical Disorders. Lomax, P. and Schonbaum E. (eds). Karger, Basel, pp. 152-156.

50. WILLCOX, B.J., POULIN, P., PITTMAN, Q.J., VEALE, W.L. (1991) Arginine vasopressin induced motor disturbances in the medial amygdala: evidence for the involvement of a V1-type of AVP receptor. Proc West Pharmacol Soc. 34:291-295

51. PITTMAN, Q.J., LANDGRAF, R. (1991) Vasopressin in thermoregulation and blood pressure control. In: Vasopressin, Vol. 208. Jard, S. and Jamison, R. (eds). John Libbey Eurotext Ltd., Paris, pp. 177-184.

52. PITTMAN, Q.J. (1991) The hypothalamus. In: The Encyclopedia of Human Biology. Dulbecco, R. (ed.) Academic Press, Inc. pp. 303-312.

53. PITTMAN, Q.J., THORNHILL, J.A. (1990) Neuropeptide mechanisms affecting temperature control. In: Current Topics in Neuroendocrinology. Vol. 10. Behavioral Aspects of Neuroendocrinology. Ganten, D. and Pfaff, D. (eds). Springer-Verlag, New York, pp. 223-241.

54. PITTMAN, Q.J. (1989) Pharmacology of ion channels (in Chinese) In: International Workshop on Neuropsychopharmacology. Basic and Clinical Aspects. WHO-AIREN, Beijing, 1989. pp. 40-51.

55. MATHIESON, W.B., VEALE, W.L., PITTMAN, Q.J. (1989) Electrophysiological evidence for involvement of the bed nucleus of the stria terminalis in fever. In: Thermoregulation: Research and Clinical Application. Lomax, P. and Schönbaum, E. (eds). Karger, Basel, pp. 61-64.

56. PITTMAN, Q.J. (1989) Brain vasopressin and cardiovascular regulation in the normotensive and hypertensive animal. In: Hans Selye Symposia: Neuropeptides and Stress. Tache, Y., Morley, J.E. and Brown, M.R. (eds). Springer-Verlag, New York, pp. 134-145.

57. WATSON, T.W., PITTMAN, Q.J. (1987) Mechanism of action of somatostatin in the hippocampal slice. Proc West Pharmacol Soc. 30:361-363.


38

58. RIPHAGEN, C.L., PITTMAN, Q.J. (1987) Intrathecal vasopressin administration alters efferent renal nerve activity. Proc West Pharmacol Soc. 30:175-177.

59. PITTMAN, Q.J., RIPHAGEN, C.L., MARTIN, S.M. (1987) Arginine vasopressin: new roles for an old peptide. In: Organization of the Autonomic Nervous System: Central and Peripheral Mechanisms. Ciriello, J., Calaresu, F.R., Renaud, L.P. and Polosa, C. (eds). A. Liss, New York, pp. 327-336.

60. PITTMAN, Q.J., MACVICAR, B.A., COLMERS, W.F. (1987) In vitro preparations for electrophysiological study of peptide neurons and actions. In: Neuromethods Vol. 6. Peptides, Boulton, A.A., Baker, G.B. and Pittman, Q.J. (eds). Humana Press, New Jersey, pp. 409-438.

61. PITTMAN, Q.J., WATSON, T.W.J. (1987) Somatostatin action in hippocampus. In: Inactivation of hypersensitive neurons. Chalazonitis, N. and Gola, M. (eds). A. Liss, New York, pp. 113-120.

62. SIGGINS, G.R., BLOOM, F.E., FRENCH, E.D., MADAMBA, S.G., MANCILLAS, J., PITTMAN, Q.J., ROGERS, J. (1987) Electrophysiology of ethanol on central neurons. Ann N Y Acad Sci. 492:350-366.

63. DISTURNAL, J.E., VEALE, W.L., PITTMAN, Q.J. (1985). Thermoresponsive units in the ventral septal area of the rat brain: evidence for involvement in AVP-induced antipyresis. In: Pharmacology of Thermoregulation. Cooper, K.E., Lomax, P., Schönbaum, E. and Veale, W.L. (eds). S. Karger, Basel, pp. 140-144.

64. BURNARD, D.M., VEALE, W.L., PITTMAN, Q.J. (1985) Arginine vasopressin: its possible involvement in febrile convulsions. In: Pharmacology of Thermoregulation. Cooper, K.E., Lomax, P., Schönbaum, E. and Veale, W.L. (eds). S. Karger, Basel, pp. 57-61.

65. PITTMAN, Q.J., DISTURNAL, J., RIPHAGEN, C.L., VEALE, W.L., BAUCE, L. (1985) Perfusion techniques for neural tissue. In: Neuromethods Vol. One, General Neurochemical Techniques. Boulton, A.A. and Baker, G.B. (eds). Humana Press, New Jersey, pp. 279-304.

66. RUWE, W.D., VEALE, W.L., PITTMAN, Q.J., KASTING, N.W., LEDERIS, K. (1985) Release of arginine vasopressin from the brain: correlation with physiological events. In: In Vivo Perfusion and Release of Neuroactive Substances. Bayon, A. and Drucker-Colin, R. (eds). Academic Press, pp. 233-248.

67. LAWRENCE, D., CIRIELLO, J., PITTMAN, Q.J., LEDERIS, K. (1984). The effect of the vasopressin antagonist d(CH2)5dTyrVAVP on the cardiovascular responses to stimulation of the paraventricular nucleus. Proc West Pharmacol Soc. 27:15-7.

68. BLOOM, F.E., SIGGINS, G.R., FOOTE, S.L., GRUOL, D., ASTON-JONES, G., ROGERS, J., PITTMAN, Q.J., STAUNTON, D. (1984) Noradrenergic involvement in the cellular actions of ethanol. In: Neurology and Neurobiology, 8B: Catecholamines, Part B: Neuropharmacology and Central Nervous System - Theoretical Aspects. Usdin, E., Carlsson, A., Dahlstrom, A. and Engel, J. (eds). A.R. Liss, New York, pp. 159-167.

69. PITTMAN, Q.J., LAWRENCE, D., LEDERIS, K. (1983). Presynaptic interactions in the neurohypophysis: endogenous modulators of release. In: The Neurohypophysis: Structure,


39

Function and Control. Progress in Brain Research, Vol. 60. Cross, B.A. and Leng, G. (eds). Elsevier Ltd., pp. 319-332.

70. BURNARD, D.M., PITTMAN, Q.J., VEALE, W.L., LEDERIS, K. (1983) Observations on the role of vasopressin in febrile convulsions. In: Environment, Drugs and Thermoregulation. Lomax, P. and Schonbaum, E. (eds). Karger, Basel, pp. 144-149.

71. LEDERIS, K., PITTMAN, Q.J., KASTING, N.W., VEALE, W.L., COOPER, K.E. (1982) Central neuromodulatory role of vasopressin in antipyresis and in febrile convulsions. Biomed. Res. 3:1-5.

72. PITTMAN, Q.J., LAWRENCE, D. (1982) Descending hypothalamic pathways: electrophysiological investigations of their possible functions. In: Neuroendocrinology of Vasopressin, Corticoliberin and Opiomelanocortins. Baertschi, A.J. and Dreifuss, J.J. (eds). Academic Press, London, pp. 167-176.

73. SIGGINS, G.R., MCGINTY, J.F., MORRISON, J.H., PITTMAN, Q.J., ZIEGLGANSBERGER, W., MAGISTRETTI, P.J., GRUOL, D.L. (1982) The role of neuropeptides in the hippocampal formation. Adv Biochem Psychopharmacol. 33:413-422.

74. PITTMAN, Q.J., ROGERS, J., BLOOM, F.E. (1982) Deficits in tolerance to ethanol in Brattleboro rats. Ann N Y Acad Sci. 394:764-766

75. DARMON, M., STALLCUP, W., PITTMAN, Q.J., SATO, G. (1982) Control of differentiation pathways by the extracellular environment in an embryonal carcinoma cell line. Cold Spring Harbour Conference on Cell Proliferation 9. Growth of Cells in Hormonally Defined Media. Sato, G.H., Pardee, A.B. and Sirbasku, D.A. (eds). pp. 997-1006

76. PITTMAN, Q.J. (1981) Peptide modulation of neuronal electrical responses. In: Adv. Physiol. Sci., Vol. 14., Endocrinology, Neuroendocrinology, Neuropeptides - 11. Stark, E. Makara, G.B., Halasz, B. and Rappay, G.Y. (eds). Pergamon Press, Akad. Kiado, Budapest, pp. 231-241.

77. BROWN, M., TACHE, Y., RIVIER, J., PITTMAN, Q.J. (1981) Peptides and regulation of body temperature. In: Neurosecretion and Brain Peptides. Implications for Brain Function and Neurological Disease. Martin, J.B., Reichlin, S. and Bick, K.L. (eds). Raven Press, New York, Adv Biochem Psychopharmacol. pp. 397-407.

78. RENAUD, L.P., PITTMAN, Q.J., BLUME, H.W., ARNAULD, E., LAYTON, B.S., BOUILLE, C., ELLIS, W.G., LAFONTAINE, S. (1981) Studies on the extra hypothalamic connections and neuropharmacology of medial hypothalamic neurons. In: Brain Mechanisms of Sensation. Katsuki, Y., Norgren, R. and Sato, M. (eds). John Wiley & Sons, New York, pp. 287-306.

79. ROSSIER, J., PITTMAN, Q.J., BLOOM, F., GUILLEMIN, R. (1980) Distribution of opioid peptides in the pituitary: a new hypothalamic-pars nervosa enkephalinergic pathway. Fed Proc. 39(8):2555-2560.

80. COOPER, K.E., VEALE, W.L., KASTING, N., PITTMAN, Q.J. (1979) Ontogeny of Fever. Fed Proc. 38(1):35-38.


40

81. RENAUD, L.P., PITTMAN, Q.J., BLUME, H.W. (1979) Neurophysiology of peptide neurons. In: Nobel Symposium 42: Central Regulation of the Endocrine System. Fuxe, K., Hokfelt, T. and Luft, R. (eds). Plenum Press, pp. 119-136.

82. RENAUD, L.P., PITTMAN, Q.J., BLUME, H.W., LAMOUR, Y., ARNAULD, E. (1979) Effects of peptides on central neuronal excitability. In: Central Nervous System Effects of Hypothalamic Hormones and Other Peptides. Collu, R., Ducharme, G.R., Barbeau, A. and Rochefort, J.G. (eds). Raven Press, New York, pp. 147-161.

83. RENAUD, L.P., BLUME, H.W., PITTMAN, Q.J. (1978) Electrophysiological approach to the putative neurotransmitter function of neuropeptides. In: Biologie Cellulaire des Processus Neurosecretoires Hypothalamiques - Cell Biology of Hypothalamic Neurosecretion. Vincent, J.D. and Kordon, C. (eds). C.N.R.S., Paris, France, pp. 669-680.

84. RENAUD, L.P., BLUME, H.W., KEARNEY, R.E., MACKENZIE, B.W., PITTMAN, Q.J. (1978) Physiological anatomy of the hypothalamus. In: Current Studies of Hypothalamic Function: 1978. Vol. 11. Metabolism and Behavior. Lederis, K. and Veale, W.L. (eds). Karger, Basel, pp. 1-16.

85. RENAUD, L.P., BLUME, H.W., PITTMAN, Q.J. (1978) Neurophysiology and neuropharmacology of the hypothalamic tuberoinfundibular system. In: Frontiers in Neuroendocrinology, Vol. 5. Ganong, W.F. and Martini, L. (eds). Raven Press, New York, pp. 135-162.

86. VEALE, W.L., COOPER, K.E., PITTMAN, Q.J. (1979) Thermoregulation in the newborn. In: Body Temperature: Regulation, Drug Effects and Therapeutic Indications. Lomax, P. and Schönbaum, E. (eds). Marcel Dekker, New York, pp. 363-382.

87. COOPER, K.E., VEALE, W.L., PITTMAN, Q.J. (1979) Pyrexia. In: Body Temperature: Regulation, Drug Effects and Therapeutic Indications. Lomax P. and E. Schönbaum, E. (eds). Marcel Dekker, New York, pp. 337-362.

88. VEALE, W.L., COOPER, K.E., PITTMAN, Q.J. (1978) Prostaglandin action on central thermoregulation and fever: ontogenetic aspects. In: Prostaglandins and Perinatal Medicine. Coceani, F. and Olley, P. (eds). Raven Press, New York, Adv Prostaglandin Thromboxane Res. pp. 199-213.

89. VEALE, W.L., COOPER, K.E., PITTMAN, Q.J. (1976) The role of prostaglandins in fever and temperature regulation. In: Prostaglandins Vol. 3. Ramwell, P. (ed.), Plenum, pp. 145-167.

90. COOPER, K.E., VEALE, W.L., PITTMAN, Q.J. (1976) The pathogenesis of fever. In: Brain Dysfunction in Infantile Febrile Convulsions, Vol. 11, I.B.R.O. Monograph Series. Brazier, M. and Coceani, F. (eds). Raven Press, New York, pp. 107-115.

91. VEALE, W.L., COOPER, K.E., PITTMAN, Q.J. (1976) Ontogenesis of thermoregulation and sensitivity to pyrogens. In: Brain Dysfunction in Infantile Febrile Convulsions, Vol. 11, I.B.R.O. Monograph Series. Brazier, M. and Coceani, F. (eds). Raven Press, New York, pp. 153-160.

92. VEALE, W.L., COOPER, K.E., PITTMAN, Q.J. (1976) Ontogenesis of thermoregulation and sensitivity to pyrogens. In: Brain Dysfunction in Infantile Febrile Convulsions, Vol. 11, I.B.R.O. Monograph Series. Brazier, M. and Coceani, F. (eds). Raven Press, New York, pp. 153-160.


41

BOOKS

1. PITTMAN, Q.J. (1986) How do we listen to neurons? Discussions in Neurosciences. 3(2):1-60.

2. A.A. BOULTON, G.B. BAKER and Q.J. PITTMAN (eds). Neuromethods: Vol. 6. Peptides. Humana Press, New Jersey. 1987, 500 pages.

MISCELLANEOUS

1. PITTMAN, Q.J. (1989) Brain peptides and seizures. Future Health, Canadians for Health Research.

2. PITTMAN, Q.J. (1991) Book review - Steve: Remembrances of Stephen Kuffler. U.J. McMahon, (ed), Sinauer Association. Can. J. Neurol. Sci. 18:309.

3. PITTMAN, Q.J. (1994) Book review - Practical Electrophysiological Methods. 2nd Edition. H. Kettenmann and R. Grantyn, (eds), Wiley-Liss. Can. J. Neurol. Sci. 21:290.

4. PITTMAN, Q.J. (1995) "Autonomic Nervous System". Open Systems for Associative Learning. Elsevier. (Computer-based Teaching Module)

5. PITTMAN, Q.J. (1997) Book Review - Biochemical Basis of Neuropharmacology. J.R. Cooper, J.E. Bloom, and R.H. Roth (eds). Can. J. Neurol. Sci. 24:(3):263.

6. PITTMAN, Q.J. (1999) The action is at the terminal. J. Physiol. (Lond). 520.3:629.

7. PITTMAN, Q.J. and MOUIHATE, A. (2003) Immune signalling to the brain. JPhysiol Perspectives 550.1:1

8. PITTMAN, Q.J., BAINS, J. (2003) Backtalk in neurons. Trends Endocrinol Metab. 14(1):2-3.

9. MOUIHATE, A., PITTMAN, Q.J. (2005) Prostaglandins in Sickness and Recovery. Assay Designs. 2:P52, Fall 2005.

10. PITTMAN, Q.J., SPENCER, S.J. (2005) Neurohypophysial peptides: gatekeepers in the amygdala. Trends Endocrinol Metab. 16(8):343-344.

11. PITTMAN, Q.J. (2006). Endothelin-an emerging role in proinflammatory pathways in brain. Am J Physiol Regul Integr Comp Physiol. 290(1):R162-163.

12. PITTMAN, Q.J. (2008) Brain adaptations for a successful pregnancy. J Physiol. 586(2):367

13. PITTMAN, Q.J., MULLIGAN, S.J. (2008) Dendritic vasopressin release: reducing the flow makes blood vessels grow. Endocrinology. 149(9):4276-4278

14. PITTMAN Q., MCGHEE, J., CHACONAS, G. (2011) The vanishing Alberta Advantage in medical research. Calgary Herald, Jan 19, 2011


42

15. PITTMAN, Q.J. (2011). Neuro-endocrinology Briefings 39: A neuroendocrine symphony. J Neuroendocrinology. 23:1296-1297

INVITED SEMINARS / HONORS

1975 Southwestern Medical School, University of Texas Health Sciences Centre at Dallas, Dallas, Texas, U.S.A.

1976 Hospital for Sick Children, Toronto, Ontario, Canada1977 National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda,

Maryland, U.S.A.1977 University of Lethbridge, Lethbridge, Alberta, Canada1977 Montreal General Hospital, Montreal, Canada1977 Montreal Neurological Institute, Montreal, Canada1977 McGill University, Dept. of Physiology, Montreal, Canada1978 Dalhousie University, Dept. of Physiology, Montreal, Canada1979 University of California, San Diego, Dept. of Neuroscience, San Diego, California, U.S.A.1979 Salk Institute, San Diego, California, U.S.A.1979 University of Calgary, Calgary, Alberta, Canada1979 University of Western Ontario, London, Ontario, Canada1979 Roche Institute for Molecular Biology, Nutley, New Jersey, U.S.A.1980 XXVIII International Congress of Physiological Sciences, Budapest, Hungary, Symposium on

"Neuropeptides as Neurotransmitters"1980 Family Practice Review and Update Program, Calgary, Alberta, Canada1980 Department of Physiology, University of Geneva, Geneva, Switzerland1981 Winter Conference on Brain Research, Keystone, Colorado, U.S.A.1981 Department of Anatomy, University of Bristol, Bristol, England1981 European Winter Conference on Brain Research, Vars, France1981 Department of Biology, University of Lethbridge, Lethbridge, Alberta, Canada1981 Neuroendocrinology Symposium. Canadian Congress of Neurology and Neurosurgery,

Calgary, Alberta, Canada1981 Thirty Second Meeting, American Society for Pharmacology and Experimental Therapeutics,

Calgary, Alberta, Canada. Symposium on "Neural peptides in homeostatic function"1982 Winter Neuropeptide Conference - Breckenridge, Colorado, U.S.A.1982 IBRO Satellite symposium on vasopressin, corticoliberin and ACTH-related peptides; Geneva,

Switzerland1982 3rd International Conference on the Neurohypophysis, Babraham, England1982 First Combined International Canadian Symposium on Alpine Rescue and its Medical

Aspects, Banff, Canada1982 The Western Hippocampus: Theoretical and Methodological Issues, Calgary, Alberta, Canada1983 Canadian Society for Clinical Investigation Symposium on "Prostaglandins and Leukotrienes

in Clinical Investigation", Calgary, Alberta, Canada1983 Department of Pharmacology, University of Alberta, Edmonton, Alberta, Canada1984 European Winter Conference on Brain Research, Courcheval, France1984 Department of Neuroendocrinology, INSERM, Paris, France1984 Physiologie Nerveuse, CNRS, Giv-sur-Yvette, France1985 Department of Zoology, University of Alberta, Edmonton, Alberta, Canada1985 Department of Physiology, Queen's University, Kingston, Ontario, Canada1985 Department of Physiology, McGill University, Montreal, Quebec, Canada1985 Department of Physiology, Université de Montreal, Montreal, Quebec, Canada1985 American Physiological Society Annual Meeting - Symposium on Neurobiology of Mammalian

Neurosecretory Neurons1985 Department of Physiology, University of Western Ontario, London, Ontario, Canada


43

1986 Organization of the Autonomic Nervous System: Central and Peripheral Mechanisms. XXX International Union of Physiological Sciences Satellite Symposium, Montreal, Quebec, Canada

1986 Inactivation of Hypersensitive Neurons. IUPS Satellite Symposium, Vancouver, British Columbia, Canada

1986 Hans Selye Symposium: Neuropeptides and Stress. Montreal, Quebec, Canada1987 Department of Biology, East China University, Shanghai, People’s Republic of China1987 Department of Physiology, Suzhou Medical College, Suzhou, People’s Republic of China1987 Department of Biology, Nanjing University, Nanjing, People’s Republic of China1987 Department of Neurology and Neurosurgery, Xuanwu Hospital & Capital Institute of Medicine,

Beijing, People’s Republic of China1987 Department of Pediatrics, Univ. of Arkansas for Medical Sciences, Little Rock, Arkansas, U.S.A.1987 Department of Physiology - Biophysics, Univ. of Arkansas for Medical Sciences, Little Rock,

Arkansas, U.S.A.1987 Department of Pharmacology, Univ. of Geneva, Geneva, Switzerland1987 Satellite Symposium to the Second World Congress of Neurosciences (IBRO) "Selected

topics in hypothalamic research". Budapest, Hungary1987 Neuroscience Discussion Group, UBC, Vancouver, Canada1988 MRC University-Industry Research Conference, Ottawa, Ontario, Canada1988 MRC Conference on Medical Research in Canada - Direction for the Future, Toronto,

Ontario, Canada1988 Joint Meeting of American Physiological Society, Canadian Physiological Society and

American Society for Pharmacology and Experimental Therapeutics, Montreal, Canada. Symposium on "Neuropeptides and Thermoregulation."

1988 Division of Preclinical Neuroscience and Endocrinology, Research Institute of the Scripps Clinic, La Jolla, California, U.S.A.

1988 Presidential Symposium - Celebration of Excellence, University of Calgary, Calgary, Alberta, Canada

1989 Department of Physiology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada1989 Department of Physiology and Biophysics, Mayo Clinic, Rochester, Minnesota, U.S.A.1989 Neuroscience Division, Upjohn Pharmaceuticals, Kalamazoo, Michigan, U.S.A.1989 Institute of Psychiatry, Beijing Medical University, Beijing, People’s Republic of China1989 Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland, Canada1989 Department of Physiology, Southwestern Medical School, Univ of Texas, Dallas, Texas, U.S.A.1989 Department of Physiology and Biophysics, Dalhousie University, Halifax, Nova Scotia, Canada1989 Neuroscience Group, Dalhousie University, Halifax, Nova Scotia, Canada1990 Winter Neuropeptide Conference, Breckenridge, Colorado, U.S.A.1990 2nd International Congress of Neuroendocrinology, Bordeaux, France1990 Third International Vasopressin Conference, Montpellier, France1990 Dept of Physiology, Oregon Health Sciences University, Portland, Oregon, U.S.A.1990 Vollum Institute, Oregon Health Sciences University, Portland, Oregon, U.S.A.1990 Symposium, Central and Peripheral Regulatory Aspects of Autonomic Function, Heritage

Days, University of Alberta, Edmonton, Alberta, Canada1991 IV International Reinhardsbrun CVO Symposium - Circumventricular Organs and Brain Fluid

Environment: Molecular and Functional Aspects. Leipzig, Germany.1991 Department of Physiology, University of Alberta, Edmonton, Alberta, Canada1991 Symposium, Canadian Federation of Biological Society - Neuropeptides in Autonomic Control,

Kingston, Ontario, Canada1992 Inserm U176, Bordeaux, France1992 Symposium, New York - Academy of Science Conference: The Neurohypophysis: A Window

on Brain Function, Dartmouth, New Hampshire, U.S.A.1993 European Winter Conference on Brain Research, La Plagne, France1993 Brain Research Institute - Amsterdam, Holland1993 CNRS URA 1200, Bordeaux, France


44

1993 Vrije University, Amsterdam, Holland1993 Inserm U259, Bordeaux, France1993 Department of Physiology, University of Lausanne, Switzerland1993 Alberta Pharmaceutical Conference, Edmonton, Alberta, Canada1994 Autonomic Nervous System Interest Group, University de Montreal, Montreal, Quebec, Canada1994 Symposium, Experimental Biology '94 - Molecular basis of fever and related host responses,

Anaheim, California, U.S.A.1994 Department of Neuropharmacology, Scripps Research Institute, La Jolla, California, U.S.A.1994 Perinatal Research Group, University of Alberta, Edmonton, Canada1994 Symposium, Development of New Antiepileptic Drugs: Basic Mechanisms and Clinical

Implementation. IUPHAR Satellite Symposium, Montreal, Quebec, Canada1994 Department of Psychology, University of Lethbridge, Lethbridge, Alberta, Canada1995 European Winter Conference on Brain Research, Alpe d'Huez, France1995 INSERM U318, Université Joseph Fournier de Grenoble, Grenoble, France1995 Department of Physiology and Biophysics, University of Tennessee Health Sciences Center,

Memphis, Tennessee, U.S.A.1995 First Joint World Congress of Neurohypophysis and Vasopressin. Nasu, Japan1996 Southern Ontario Neuroscience Association - Grass Visiting Lecturer, Toronto, Ontario, Canada1996 Department of Physiology, Queen's University, Kingston, Ontario, Canada1996 Department of Biological Sciences, University of Alberta, Edmonton, Alberta, Canada1997 Department of Physiology, University of Texas Health Sciences Center, San Antonio, Texas,

U.S.A.1997 International Union of Physiological Sciences Congress (IUPS), St. Petersburg, Russia1997 World Congress of Neurohypophysial Hormones, Montreal, Quebec, Canada1997 Molecular Mechanisms of Fever, Santa Fe, New Mexico, U.S.A.1997 Dept. of Psychology, University of Iowa, Iowa City, Iowa, U.S.A.1998 Neuroscience Institute, University of Ottawa, Ontario, Canada1998 Institut fur Medizinische Neurobiologie, Otto-Von-Guericke-Universitat Magdeburg, Germany1998 1998 Forum of European Neuroscience, Berlin, Germany1998 Dept. of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada1998 4th Intl. Congress of Neuroendocrinology, Kitakyushu, Japan1998 The Paraventricular Nucleus of the Hypothalamus: Crossroads of Integrative

Physiology. 1998 American Physiological Society Conference, San Antonio, Texas, U.S.A.1998 WHO Meeting on the Autonomic Nervous System, Bethesda, Maryland, U.S.A.1999 Department of Biology, University of Lethbridge, Lethbridge, Alberta, Canada1999 Department of Psychology, University of Lethbridge, Lethbridge, Alberta, Canada1999 Department of Physiology, University of Alberta, Edmonton, Alberta, Canada1999 Unite de Neuroscience, Centre de Recherche du CHUL, Ste.-Foy, Quebec, Canada1999 World Congress on Neurohypophysial Hormones, Edinburgh, Scotland2000 Montreal Neurological Institute and Hospital and McGill University, Montreal, Quebec, Canada2000 CANIB Symposium on Neuroimmune Biology, University of Manitoba, Winnipeg, Manitoba, Canada2000 Department of Pharmacology, University of Alberta, Edmonton, Alberta, Canada2001 Canadian Centre for Behavioral Neuroscience, Opening Symposium, University of Lethbridge

Lethbridge, Alberta, Canada2001 Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, Ontario, Canada2001 Department of Pharmacology, University of Alberta, Edmonton, Alberta, Canada2001 World Congress on Neurohypophysial Hormones, Bordeaux, France (Session Chair)2002 Max Planck Institute of Psychiatry, Munich, Germany2002 6th Cayman Peptide Conference, Turks and Cacaos2002 International Neuroendocrine Federation, Bristol, UK (Session Chair)2002 University of Regensburg, Regensburg, Germany2003 University of Calgary, Brain Awareness Day 2003, Calgary, Alberta, Canada2003 Neuroscience Research Group, University of Tennessee, Memphis, Tennessee, U.S.A.2003 13th Annual GastroIntestinal Research Group Retreat, Banff, Alberta, Canada


45

2003 2nd Magnocellular Neurophysiology Workshop, Tulane University, New Orleans, Louisiana, U.S.A.2003 World Conference of Neurohypophysial Hormones, Kyoto, Japan2003 Department of Intelligence Science and Technology, Kyoto University, Kyoto, Japan2003 5th International Workshop of the University of Occupational and Environmental Health,

Kitakyushu, Japan2003 International Society for Autonomic Neuroscience (Session Chair), Calgary, Alberta, Canada2003 CV Therapeutics, Palo Alto, California, U.S.A.2003 Douglas Hospital Research Center, McGill University, Montreal, Canada2004 Department of Physiology and Neuroscience, University of Wyoming, U.S.A.2004 Department of Biomedical Science, University of Edinburgh, Scotland2004 Department of Pharmacological & Physiological Sciences, Saint Louis University, St. Louis,

Missouri, U.S.A.2004 Federation of European Neuroscience Societies (FENS), Lisbon, Portugal2004 Tulane University, New Orleans, Louisiana U.S.A.2004 Department of Physiology, Queen’s University, Kingston, Ontario, Canada2005 13th Annual Physiology Student Research Day, University of Alberta, Edmonton, Alberta, Canada2005 CV Therapeutics, Palo Alto, California, U.S.A.2005 17th Canadian Spring Conference on Behaviour and Brain, Fernie, British Columbia, Canada2005 IBRO Neuroscience School in Rabat, Africa 2005 APS Conference: Neurohypophyseal Hormones: From Genomics and Physiology to Disease,

Steamboat Springs, Colorado, U.S.A.2005 Canadian League Against Epilepsy-Canadian Epilepsy Research Interest Group Retreat,

Ottawa, Ontario, Canada2005 Department of Physiology, University of Toronto, Toronto, Ontario, Canada2005 Department of Physiology and Pharmacology, Drexel University School of Medicine,

Philadelphia, U.S.A.2006 Sigma Xi Society, University of Calgary, Alberta, Canada2006 12th Annual Child Health Research Symposium - The effects of seizures on the developing brain.

Alberta Children’ Hospital, Calgary, Alberta, Canada2006 Renaud Symposium, Canadian Physiological Society2006 Alberta Obesity Summit, Kananaskis Village, Alberta, Canada2006 Dept of Physiology and Pharmacology, Oregon Health & Science University, Portland Oregon,

USA2006 International Congress of Neuroendocrinology, Symposium on “Endocannabinoids”

Pittsburgh, Pennsylvania, USA2006 International Symposium of Neuroendocrinology, “Neuroendocrine Control of Body Fluid

Homeostasis: Past, Present, and Future.” Ribeirao Preto, Brazil2006 Canadian Diabetes Association 10th Annual meeting; Symposium on Brain and Metabolism,

Toronto, Ontario, Canada2006 Centre for Neuroscience, University of Alberta, Edmonton, Alberta, Canada2006 Round Table: Basic Mechanisms of Epilepsy- Animal Models of Febrile Seizures and Febrile

Status Epilepticus: What do they tell us about Epilepsy? American Epilepsy Society,San Diego, California, U.S.A.

2007 Perinatal physiology: from uterus to brain, Focused meeting - The Physiological Society, Edinburgh, United Kingdom

2007 Neuroscience program, Uniformed Services University of the Health Sciences, Bethesda Maryland, U.S.A.

2007 Molecular and Integrative Neurosciences Department, Scripps Research Institute, La JollaCalifornia, U.S.A.

2007 INSERM U732, Paris, France2007 International Brain Research Organization, Melbourne, Australia2007 Life Sciences 2007, Glasgow, United Kingdom


46

2007 The Physiological Society & Slovakian Physiological Society & FEPS, Bratislava, Slovakia2008 CIHR Café Scientifique, University of Lethbridge2008 Mini Med School, University of Calgary2008 Sarrazin Lecture, Canadian Physiological Society, Lake Louise, Alberta, Canada2008 Distinguished Integrative Physiology Lecture, University of Saskatchewan, Saskatoon,

Saskatchewan, Canada2008 7th Canadian Epilepsy Research Initiative, Canadian League Against Epilepsy, London,

Ontario, Canada2008 Colloquium, Carleton University, Ottawa, Ontario, Canada2008 Neuroscience and Behavior Colloquium, University of Massachusetts Amherst, Amherst,

Massachusetts, U.S.A.2009 Society for Integrative and Comparative Biology (SICB), Boston, Massachusetts, U.S.A.2009 Center for Studies in Behavioral Neurobiology (CSBN), Concordia University, Montreal,

Quebec, Canada2009 EpiCenter Seminar, University of California, Irvine, California, U.S.A.2009 Stress Club Seminar, University of California, Irvine, California, U.S.A.2009 Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada2009 Institute for Child and Maternal Health: Reproductive, Maternal, Fetal & Newborn Health - 1st

Annual Research Symposium, University of Calgary, Calgary, Alberta, Canada2009 3rd Annual Canadian Neuroscience Meeting, Vancouver, British Columbia, Canada2009 44th Annual Congress of the Canadian Neurological Sciences Federation, Halifax, Nova

Scotia, Canada2009 McMaster University, Farncombe Family Digestive Health Research Institute, Hamilton,

Ontario, Canada2009 University of British Columbia, Department of Anesthesiology, Pharmacology and

Therapeutics, Visiting Guest Professor of Pharmacology, External Guest Judge, 3rd Annual Research Day

2009 Festschrift Symposium in Honour of Professor John A. Russell, Edinburgh, United Kingdom2009 Inflammation Research Network Seminar, University of Calgary, Calgary, Alberta, Canada2009 19th Iranian Congress of Physiology and Pharmacology, Tehran, Iran 2009 American Epilepsy Society Annual Meeting – Investigators’ Workshop: The impact of

neuroinflammation on neuronal excitability and excitotoxicity, Boston, MA, U.S.A.2010 Neuroinflammation Training Program, Montreal Neurological Institute, McGill University, Montreal,

Quebec, Canada2010 Department of Physiology, University of Alberta, Edmonton, Alberta, Canada2010 Neural Plasticity Conference, Canadian Centre for Behavioural Neuroscience, University of

Lethbridge, Lethbridge, Alberta, Canada2010 Panel Member, Course in Scientific Management and Leadership, University of Pittsburgh,

Pittsburgh, PA, USA 2010 Research Day, External Adjudicator, Department of Pharmacology, University of Alberta,

Edmonton, Alberta, Canada2010 4th Annual Canadian Neuroscience Meeting, Ottawa, Ontario, Canada 2010 2010 FASEB Summer Research Conferences, Saxtons River, Vermont, USA 2010 Immunity and Inflammation in Epilepsy 2010, Milan, Italy 2010 2010 Society for Neuroscience Satellite Symposium - National Institute on Alcohol Abuse and

Alcoholism, Neuroimmune mechanisms of brain function and alcohol-related disorders, San Diego, California, USA

2011 Department of Pharmaceutical Sciences Seminar Series, Albany College of Pharmacy and Health Sciences, Albany, New York, USA

2011 Physiology Seminar, University of Maryland School of Medicine, Baltimore, MD, U.S.A.2011 50th Anniversary Symposium, Department of Pharmacology, University of Alberta, Edmonton


47

2011 Sex, Stress, Immunity, and Neural Development, Society for Neuroscience Symposium, Washington, DC

2012 Physiology and Pharmacology of Temperature Regulation, Buzios, Brazil2012 Barrow Neurological Institute, Phoenix Arizona2012 The Role of TNF in Brain Dysfunction and Disease, Neurex Symposium, Basel Switzerland2012 Dept of Basic Medical Sciences, The University of Arizona College of Medicine, Arizona, USA

Phoenix2012 10th European Congress on Epileptology, London, England 2012 Society for Neuroscience Annual Meeting; symposium on Brain-Body Communication: Function

and Dysfunction and the Critical Role of the Immune System, New Orleans2012 Calgary Epilepsy Day- Mary Ann Lee Symposium2012 Canadian League Against Epilepsy Symposium: Basic science of Epilepsy and Clinical relevance,

Calgary2012 Medical Sciences Division Seminar Series, Northern Ontario School of Medicine, Laurentian

University, Sudbury, Ontario, Canada2013 Banff Inflammation Workshop, Banff, Alberta, Canada2013 University of Helsinki, Helsinki, Finland2013 Lundbeck, Copenhagen, Denmark2013 10th World Congress on Neurohypophysial Hormones, Mortyn Jones Memorial Lecture, Bristol,

England.2013 36th Naito Conference, Sapporo, Japan2014 Plenary Lecture. Pan American Congress of Physiological Sciences, Brazil, South America2014 Bristol-Sao Paulo Research Summit, Brazil, South America2014 Centre for Brain and Mental Health, University of Newcastle, Australia2014 5th International Symposium on the Physiology and Pharmacology of Temperature Regulation,

Kruger National Park, South Africa2014 9th Congress of the International Society for NeuroImmunoModulation, Liege, Belgium2014 Snyder Institute for Chronic Diseases Research Day, Calgary 2015 Penn State School of Medicine, Hershey Pennsylvania2015 Institute of Neuroscience and Dept. of Pharmacology, University of Alberta, Edmonton2015 Robarts Institute, University of Western Ontario, London, Ontario2015 1st German Neuropeptide Symposium, Regensburg, Germany2015 Neuroretreat Hooks Herrgard, Linkoping University, Sweden2015 Neurophysiology Colloquium Series, UNAM, Mexico City, Mexico2016 Dept. of Cell, Developmental and Integrative Biology, University of Alabama, Birmingham2016 Experimental Biology 2016, San Diego California (Award lecture)2016 Immunity and Inflammation in Epilepsy; IIL2016, Milan2016 Neuroimmunophysiology of the Gastrointestinal Tract, Banff, Alberta2017 From the Bedside to Neurons and Back, Ottawa, Ontario


48

Documents

CURRICULUM VITAE - ucalgary.ca · Web view1995-2000Alberta Heritage Foundation for Medical Research Scientist (competition renewal)